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Abstract
This thesis characterizes and explores the role of thymic stromal lymphopoietin (TSLP) – TSLP receptor
(TSLPR) interactions in the regulation of intestinal immunity and inflammation. TSLP is known to promote
TH2 cytokine-mediated inflammation in the skin and the lung. Firstly, this thesis focuses on the
characterization of TSLP and TSLPR expression within the gastrointestinal (GI) tract and in the immune
cells of the associated lymphoid tissues. Our findings suggest that TSLP is primarily produced by intestinal
epithelial cells (IECs) under homeostatic conditions. Expression of the heterodimeric TSLPR complex was
exhibited on gut-associated lymphoid tissue (GALT) CD4+ T cells and CD11c+ dendritic cells (DCs) as well
as on splenic mast cells and basophils in naïve mice. Second, this thesis explores the role of TSLP in the
generation of a TH2 cytokine-mediated host-protective immune response to the gastrointestinal helminth
pathogen Trichuris muris. We demonstrate that in an intact animal TSLP-TSLPR interactions are critical for
resistance to Trichuris as disruption of the TSLP-TSLPR pathway either through genetic deletion of the
TSLPR, or antibody-mediated depletion of TSLP, resulted in susceptibility to infection. Further, these mice
exhibited increased infection-induced proinflammatory cytokine production and inflammation. However,
TSLP-TSLPR interactions were not required for the generation of a host-protective TH2 cytokine-mediated
immune response to Trichuris in the absence of IFN-γ, indicating TSLP-independent intestinal TH2 immune
responses. Third, we examine the potential for TSLP-TSLPR interactions to regulate intestinal
proinflammatory cytokine production. Examination of naïve TSLPR-/- mice revealed a trend towards
increased CD4+ T cell production of IFN-γ in the GALT compared to TSLPR+/+ mice. Further, TSLPR-/-
mice were more susceptible to DSS-induced colitis, exhibiting increased proinflammatory cytokine
production and more severe intestinal inflammation compared to control mice. We demonstrate that TSLP
can regulate DC-derived IL-12/23p40 production both in vitro and in vivo and that rTSLP is able to inhibit
CD4+ T cell production of IFN-γ in splenocyte cultures in the absence of IL-4. Taken as a whole, this thesis
identifies an important role for TSLP-TSLPR interactions in regulating intestinal immunity and inflammation
and in the maintenance of intestinal immune homeostasis.
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Abstract 
 
TSLP regulates intestinal immunity and inflammation 
Betsy C. Taylor 
David Artis 
 
This thesis characterizes and explores the role of thymic stromal lymphopoietin (TSLP) – 
TSLP receptor (TSLPR) interactions in the regulation of intestinal immunity and 
inflammation.  TSLP is known to promote TH2 cytokine-mediated inflammation in the skin 
and the lung.  Firstly, this thesis focuses on the characterization of TSLP and TSLPR 
expression within the gastrointestinal (GI) tract and in the immune cells of the associated 
lymphoid tissues.  Our findings suggest that TSLP is primarily produced by intestinal 
epithelial cells (IECs) under homeostatic conditions.  Expression of the heterodimeric 
TSLPR complex was exhibited on gut-associated lymphoid tissue (GALT) CD4+ T cells 
and CD11c+ dendritic cells (DCs) as well as on splenic mast cells and basophils in naïve 
mice.  Second, this thesis explores the role of TSLP in the generation of a TH2 cytokine-
mediated host-protective immune response to the gastrointestinal helminth pathogen 
Trichuris muris.  We demonstrate that in an intact animal TSLP-TSLPR interactions are 
critical for resistance to Trichuris as disruption of the TSLP-TSLPR pathway either 
through genetic deletion of the TSLPR, or antibody-mediated depletion of TSLP, resulted 
in susceptibility to infection.  Further, these mice exhibited increased infection-induced 
proinflammatory cytokine production and inflammation.  However, TSLP-TSLPR 
interactions were not required for the generation of a host-protective TH2 cytokine-
mediated immune response to Trichuris in the absence of IFN-γ, indicating TSLP-
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independent intestinal TH2 immune responses.  Third, we examine the potential for 
TSLP-TSLPR interactions to regulate intestinal proinflammatory cytokine production.  
Examination of naïve TSLPR-/- mice revealed a trend towards increased CD4+ T cell 
production of IFN-γ in the GALT compared to TSLPR+/+ mice.  Further, TSLPR-/- mice 
were more susceptible to DSS-induced colitis, exhibiting increased proinflammatory 
cytokine production and more severe intestinal inflammation compared to control mice. 
We demonstrate that TSLP can regulate DC-derived IL-12/23p40 production both in vitro 
and in vivo and that rTSLP is able to inhibit CD4+ T cell production of IFN-γ in splenocyte 
cultures in the absence of IL-4.  Taken as a whole, this thesis identifies an important role 
for TSLP-TSLPR interactions in regulating intestinal immunity and inflammation and in 
the maintenance of intestinal immune homeostasis. 
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Chapter 1: Literature Review 
The intestinal immune system 
Balancing immunity and inflammation in the intestine 
The intestinal tract is the largest mucosal surface of the human body, with a surface area 
of approximately 100-200 m2 (Mason 2008), and presents an immense immunologic 
challenge to the host.  The large amount of exposed surface area is vulnerable to 
invasion by pathogenic bacteria, viruses, fungi, and parasites.  However, despite the 
need to remain responsive against pathogenic microbes, the gastrointestinal (GI) tract 
must also remain hyporesponsive to innocuous stimuli.  Due to its function in the 
absorption of nutrients and minerals, the intestine is continually exposed to large 
quantities of food and environmental antigens.  Additionally, the adult human intestine is 
colonized by an estimated 1014 “commensal” bacteria (Ley, Peterson et al. 2006; Frank 
and Pace 2008), which exist in a mutualisitic relationship with the host.  In fact, the 
presence of commensal bacteria is required for normal development of the immune 
system, and they play important roles in the supply of essential nutrients, the breakdown 
of indigestible materials, and in the defense against opportunistic pathogens (Artis 2008; 
Round and Mazmanian 2009).  Loss of hyporesponsiveness to environmental, food, and 
commensal-derived antigens leads to inflammation and disease states ranging from food 
allergy to inflammatory bowel disease (IBD) (Bouma and Strober 2003; Macdonald and 
Monteleone 2005; Karin, Lawrence et al. 2006). 
 
In order to contend with these diverse challenges, the intestinal immune system has 
developed a complex combination of both anatomic and immunological adaptations that 
help maintain host immune homeostasis.  One of the most important anatomic features 
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of the intestine is the separation of the external environment from the sterile tissues of 
the body by a single layer of intestinal epithelial cells.   
 
Intestinal epithelial cells (IECs) form a physical barrier 
IECs have developed numerous adaptations that allow them to physically separate the 
contents of the lumen of the gut from the cells of the lamina propria.  The apical surface 
of IECs is covered in microvilli, a dense network of actin filaments and membrane 
invaginations that combine to form the brush border.  The brush border not only 
increases the surface area of the cell allowing maximal absorption of nutrients, but also 
serves to separate luminal contents from the main IEC cell body (Sansonetti 2004).  
Additionally, IECs are directly interconnected through a series transmembrane proteins 
including claudins that form tight junctions.  Tight junctions prevent the translocation of 
bacteria between cells and are actively regulated to allow selective permeability of the 
barrier (Sansonetti 2004).  The cellular barrier is also reinforced chemically, as goblet 
cell-derived mucins bind the apical surface of IECs to form a glycocalyx, and further 
mucin production results in a thick layer of mucus that acts as a semi-permeable barrier 
that traps bacteria and sequesters them away from direct contact with IECs (Sansonetti 
2004).  IECs also possess antimicrobial properties: they secrete defensins, cathelicidins, 
and calprotectins whose amphipathic nature allows for insertion into and disruption of 
bacterial cell walls (Ganz 2003; Salzman, Ghosh et al. 2003; Agerberth and 
Gudmundsson 2006).  IEC production of antimicrobial products helps to control and 
regulate bacterial growth, while also helping to prevent live bacteria from directly 
contacting IECs.  Together, these IEC adaptations combine to make a substantial 
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physical barrier separating potentially pathogenic external stimuli from the lamina propria 
and are critical in the maintenance of intestinal immune homeostasis.   
 
IECs actively modulate intestinal immune responses 
In addition to providing a physical barrier, IECs also actively respond to and interact with 
their environment.  IECs are known to express a wide variety of pattern-recognition 
receptors including members of the Toll-like receptor (TLR) family and the nucleotide-
binding oligomerization domain (NOD)-like receptors (NLRs) (Artis 2008; Gribar, 
Richardson et al. 2008), which have been demonstrated to be important in the 
maintenance of intestinal immune homeostasis (Rakoff-Nahoum, Paglino et al. 2004).  
Importantly, IECs can discriminate between commensal and pathogenic organisms, 
helping to maintain the balance between immunity and inflammation.  Possible 
mechanisms that allow for the selective activation of IECs by pathogenic bacteria 
compared to commensal bacteria include the selective and regulated expression of 
TLRs and NLRs, apical versus basolateral expression of TLRs, and the modulation of 
IEC signaling pathways by commensal bacteria (Neish, Gewirtz et al. 2000; Kelly, 
Campbell et al. 2004; Artis 2008).   
 
When infected by enteropathogenic bacteria, IECs maintain the ability to respond and 
upregulate a diverse array of immune response genes.   Activation results in the 
induction of cytokines including IL-8 and TNF-α as well as the expression of chemokines 
such as CCL2 (Eckmann, Kagnoff et al. 1993; Jung, Eckmann et al. 1995; Yang, 
Eckmann et al. 1997).  These factors act to activate resident immune cells and to recruit 
monocytes to the site of infection, thus initiating the immune response. IEC recognition 
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of pathogenic bacteria is important in the initiation of protective immune responses.  
Deletion of the pattern recognition receptors TLR4 or NOD1 or the central TLR signaling 
molecule MyD88 in non-haematopoietic cells resulted in impaired immunity following 
bacterial infection (Schilling, Martin et al. 2003; Brandl, Plitas et al. 2007; Lebeis, 
Bommarius et al. 2007). The NF-κB signaling pathway appears to be a central regulator 
in IEC activation as multiple types of enteroinvasive bacteria activate the pathway and 
induce nuclear localization and DNA binding of NF-κB in IECs (Elewaut, DiDonato et al. 
1999). 
 
In addition to responding to bacterial invasion, IEC-intrinsic NF-κB signaling is critical to 
maintaining intestinal immune homeostasis.  Mice with an IEC-specific deletion of IKK-γ 
(also known as NEMO), a critical regulator protein of the NF-κB pathway that is essential 
to both classical and non-classical NF-κB signaling, develop spontaneous colitis (Nenci, 
Becker et al. 2007).  Loss of NEMO within IECs results in impaired IEC barrier function, 
with increased colonic IEC apoptosis, decreased antimicrobial peptide production, and 
translocation of bacteria into the lamina propria.  Conditional ablation of either IKK-β or 
IKK-α specifically in IECs did not result in the development of spontaneous colitis in 
mice, indicating that suboptimal NF-κB signaling is sufficient to maintain barrier integrity 
(Nenci, Becker et al. 2007).  However, when challenged with the intestinal helminth 
pathogen Trichruis muris, mice specifically lacking IKK-β in IECs exhibited increased 
susceptibility, increased proinflammatory cytokine production, and severe infection-
induced inflammation compared to littermate control mice (Zaph, Troy et al. 2007).  
These results implicate the NF-κB pathway as a central regulator of intestinal immune 
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homeostasis and in the development of host-protective immune responses to a broad 
spectrum of intestinal pathogens.  
 
IECs modulate downstream responses through the regulated secretion of a number of 
immunomodulatory factors including IL-10, prostaglandin E2 (PGE2), transforming growth 
factor-β (TGF-β), and thymic stromal lymphopoietin (TSLP).  IECs have been 
demonstrated to produce the anti-inflammatory cytokine IL-10 constitutively (Jarry, 
Bossard et al. 2008), which can inhibit proinflammatory cytokine production from 
macrophages and dendritic cells (DCs) (Mosser and Zhang 2008).  PGE2 inhibits DC 
production of IL-12 if present during priming, favoring the differentiation of naïve CD4+ T 
cells into TH2 cells.  Further, PGE2 can act directly on CD4+ T cells to down modulate 
their production of IFN-γ (Harris, Padilla et al. 2002).  IECs constitutively secrete large 
amounts of TGF-β (Barnard, Warwick et al. 1993), which potently inhibits 
proinflammatory cytokine production from macrophages and DCs and plays a role in the 
differentiation of both regulatory T cells and TH17 cells (Rubtsov and Rudensky 2007).  
IECs also express TSLP, a cytokine implicated in the maintenance of intestinal immune 
homeostasis through its modulation of DC function (Rimoldi, Chieppa et al. 2005).  This 
thesis will investigate the role of TSLP in the intestinal immune system. 
 
Thymic stromal lymphopoietin (TSLP) 
Cellular sources and regulation of TSLP 
While TSLP was initially identified and characterized as a novel cytokine produced by 
thymic stromal cells (Friend, Hosier et al. 1994; Sims, Williams et al. 2000; Quentmeier, 
Drexler et al. 2001), it is predominantly expressed in epithelial cells of the skin 
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(keratinocytes), lung (small airway epithelial cells), and intestine (IECs) (Sims, Williams 
et al. 2000; Reche, Soumelis et al. 2001; Soumelis, Reche et al. 2002; Liu, Soumelis et 
al. 2007).  Basal expression of TSLP mRNA in the steady state has been detected in 
epithelial cells of the tonsils, skin, lung, and intestine (Soumelis, Reche et al. 2002; Liu, 
Soumelis et al. 2007; Zaph, Troy et al. 2007); however, the basal production of TSLP 
protein has only been found in the lung, tonsils, and intestine (Watanabe, Hanabuchi et 
al. 2004; Rimoldi, Chieppa et al. 2005; Zhang, Shan et al. 2007).  Structurally, TSLP 
resembles IL-7 and is a four-helix bundle cytokine.  There is no cross-species reactivity 
between human and murine TSLP; they exhibit only 43% amino acid sequence identity 
(Liu, Soumelis et al. 2007). However, despite these substantial molecular differences, 
human and murine TSLP exert similar biological functions. 
 
Increased TSLP expression in epithelial cells can be induced through exposure to viral, 
bacterial, or parasitic pathogens as well as ligation of Toll-like receptors (TLRs) 
(Allakhverdi, Comeau et al. 2007; Kato, Favoreto et al. 2007; Humphreys, Xu et al. 2008; 
Zeuthen, Fink et al. 2008; Kinoshita, Takai et al. 2009; Ramalingam, Pesce et al. 2009).  
Treatment with extract from the common environmental fungus, Alternaria alternata, 
resulted in TSLP induction in airway epithelial cells (Kouzaki, O'Grady et al. 2009), 
indicating allergen-driven TSLP expression.  Exposure to proinflammatory cytokines 
such as IL-1β and TNF-α, or to TH2 cell-associated cytokines IL-4 and IL-13 alone or in 
combination has also been shown to induce the expression of TSLP (Bogiatzi, 
Fernandez et al. 2007; Kato, Favoreto et al. 2007; Lee and Ziegler 2007; Zhang, Shan et 
al. 2007; Miyata, Nakamura et al. 2009; Tanaka, Saga et al. 2009).  Interestingly, 
administration of IL-13 was able to induce STAT6-dependent TSLP production in murine 
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epithelial cells from nasal, tracheal, lung, and skin explants, but not from the intestine 
(Miyata, Nakamura et al. 2009), indicating the possibility that tissue-specific regulatory 
mechanisms may exist.  In addition to IL-13, treatment of a lung epithelial cell line, 
MLE12, with IL-25, another cytokine associated with the promotion of TH2 cytokine-
dependent immune responses, resulted in increased TSLP expression (Angkasekwinai, 
Park et al. 2007).  Further, treatment with the TH2-associated cytokine IL-33 increased 
TSLP mRNA expression in cecal tissues of mice infected with Trichuris muris 
(Humphreys, Xu et al. 2008).  
 
Examination of the promoter regions for both human and murine TSLP revealed an NF-
κB-binding site that is responsible for increased TSLP expression following exposure to 
IL-1β and TNF-α (Lee and Ziegler 2007).  Recent studies focusing on keratinocyte 
biology have found that epidermal kallikrein (KLK5), a serine protease, upregulates 
TSLP expression in human keratinocytes through the activation of proteinase-activated 
receptor 2 (PAR2) in a NF-κB-dependent manner (Briot, Deraison et al. 2009).  PAR2 
was additionally shown to be important since siRNA-mediated knockdown of PAR2 
expression inhibited TSLP production in response to both the allergen-derived cysteine 
protease papain and the prototypic protease trypsin in airway epithelial cells (Kouzaki, 
O'Grady et al. 2009)  However, papain-induced TSLP expression was not entirely 
dependent upon PAR2, indicating the presence of additional mechanisms (Kouzaki, 
O'Grady et al. 2009).  Consistent with a role for allergens in the induction of TSLP, both 
TSLP mRNA and protein were found to be dynamically upregulated in the dermis of 
atopic patients during allergen-induced late phase cutaneous responses (Corrigan, 
Jayaratnam et al. 2009).  Clinical studies examining genetic variants of the tslp gene in 
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bronchial epithelial cells from 36 patients identified a single nucleotide polymorphism 
(SNP) in the promoter region of the long-form tslp that enhanced binding of the 
transcription factor activating protein (AP)-1 and increased promoter-reporter activity in 
response to stimulation (Harada, Hirota et al. 2009).  These findings implicate for the first 
time a role for genetic polymorphisms in the regulation of TSLP expression. 
 
There is speculation that TSLP can influence wound healing as expression can be 
upregulated by damage or trauma to epithelial cells (Allakhverdi, Comeau et al. 2007) 
(Figure 1).  Also, TSLP treatment of human nasal epithelial cells in vitro resulted in 
enhanced barrier function and increased expression of the tight-junction proteins claudin 
-1, -4, -7, and occludin (Kamekura, Kojima et al. 2009).  Further, studies examining the 
link between cigarette smoking and asthma have found that intranasal administration of 
cigarette smoke extract to mice upregulates TSLP mRNA and protein in the lung in an 
oxidative-stress dependent manner (Nakamura, Miyata et al. 2008).   Also, clinical 
studies utilizing both bronchial biopsies and bronchoalveolar lavage (BAL) fluid samples 
found significantly elevated levels of TSLP mRNA positive cells and protein in patients 
with asthma or chronic obstructive pulmonary disease (COPD) compared to healthy, 
never-smoking controls (Ying, O'Connor et al. 2008).  Although the molecular mediators 
and mechanisms of action remain unknown, recent work suggests that mast cells may 
also induce TSLP expression in epithelial cells, as mast cell-deficient mice fail to 
upregulate TSLP in a model of allergic rhinitis (Miyata, Hatsushika et al. 2008).  These 
findings indicate a role for communication between immune cells and epithelial cells in 
the induction of TSLP expression.   
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In addition to microbial-derived signals, host-derived cytokines, and cell damage, nuclear 
receptors may also play a role in the regulation of TSLP.    Ablation of retinoid X receptor 
in keratinocytes induced increased TSLP expression in these cells (Li, Messaddeq et al. 
2005).  Supporting this, treatment of normal keratinocytes with the nuclear receptor 
agonist vitamin D3 or low-calcemic analogs elevated TSLP production (Li, Hener et al. 
2006).  A summary of factors known to induce TSLP expression is depicted in Figure 1 
and included in Table 1. 
 
While the majority of studies to date have focused on the identification of factors known 
to induce TSLP production in epithelial cells, several factors have been identified that 
may be able to negatively regulate TSLP expression.  Treatment of airway epithelial 
cells or primary human keratinocytes with glucocorticoids was sufficient to inhibit 
dsRNA-induced TSLP expression (Le, Takai et al. 2009; Miyata, Nakamura et al. 2009).  
Interestingly, topical administration of glucocorticoids is commonly used to treat patients 
with atopic dermatitis (Norris 2005), suggesting that one potential mechanism of action 
of the drug is the inhibition of TSLP production.  Also, one study has recently proposed 
that 9-cis-retinoic acid may act to negatively regulate TSLP expression in airway 
epithelial cells (Lee, Headley et al. 2008).  Given the findings that TSLP can be induced 
by both exogenous stimuli (damage, infection, TLR ligation) and host-derived signals, 
TSLP production by epithelial cells and its regulation may represent a critical pathway 
through which epithelial cells and the immune system communicate (Figure 1). 
 
Although the current literature indicates that epithelial cells are a dominant source of 
TSLP, reports have identified hematopoietic cell-derived TSLP as mast cells and 
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basophils have been shown to express TSLP following stimulation.  Mast cells were first 
identified as a possible source of TSLP when TSLP mRNA expression was examined in 
cDNA libraries from different primary cells.  In contrast to constitutive production of TSLP 
by IECs, TSLP expression in mast cells requires stimulation, as cross-linking of the IgE 
receptor on mast cells results in elevated levels of TSLP mRNA (Soumelis, Reche et al. 
2002).  More recent data suggest that mast cell production of TSLP may be specific to 
IgE cross-linking, as treatment of mast cells with LPS, polyI:C , and IL-4 failed to induce 
TSLP mRNA expression.  However, preincubation with IL-4 prior to IgE cross-linking 
significantly increased mast cell TSLP expression (Okayama, Okumura et al. 2009).  
Examination of suppressor of cytokine signaling 7 (SOCS7) in mast cells revealed a 
novel regulatory role for SOCS7 in the inhibition of TSLP production, as bone marrow-
derived mast cells from Socs7 deficient mice exhibit increased production of TSLP 
compared to wild type (WT) controls following FcεRI-mediated activation (Knisz, Banks 
et al. 2009).  Similar to mast cells, basophils do not appear to express TSLP in a resting 
state.  However, basophils stimulated with papain upregulate both TSLP mRNA and 
protein (Sokol, Barton et al. 2008).  While mast cells and basophils make TSLP in vitro, 
the contribution of these cellular sources in vivo remains to be fully ascertained.  
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Figure 1 Regulation of TSLP production 
Figure 1  Epithelial cells are a source of TSLP.  TSLP expression is induced 
following exposure to both external and host-derived stimuli.  Modified from Saenz, 
Taylor et al. 2008 
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Cellular targets of TSLP 
TSLP-TSLPR signaling 
High affinity ligand binding of TSLP and subsequent signaling requires a heterodimeric 
receptor consisting of the IL-7Rα chain (CD127) and a unique TSLPR-α chain that 
resembles the common cytokine receptor γ chain (γc) (Park, Martin et al. 2000; Reche, 
Soumelis et al. 2001).  Despite poor sequence homology between human and mouse 
TSLPR, both activate similar signaling pathways.  Ligation of TSLPR leads to the 
downstream phosphorylation and activation of signal transducer and activator of 
transcription (STAT) 5 and STAT3 in mice, and STAT5 in humans (Isaksen, Baumann et 
al. 1999; Levin, Koelling et al. 1999; Sebastian, Borowski et al. 2008).  TSLP-mediated 
STAT5 activation appears to be independent of any of the four Janus kinases (JAKs), 
however, partial abrogation of TSLP-mediated STAT5 phosphorylation was observed in 
cells expressing a dominant negative form of Tec kinase, indicating possible Tec family 
kinase involvement in TSLP signaling (Isaksen, Baumann et al. 1999; Levin, Koelling et 
al. 1999; Reche, Soumelis et al. 2001; Liu, Soumelis et al. 2007) (Figure 2).  Also, 
studies indicate that TSLP signaling does not result in the activation of either ERK1/2 or 
p70S6K (Quentmeier, Drexler et al. 2001).  These findings suggest that neither the 
mitogen-activated protein kinase (MAPK) pathway nor the p70S6K pathway are involved 
in TSLP-elicited signal transduction.  The specific involvement of tyrosine kinases, their 
association with TSLPR, and the subsequent gene targets of TSLP-TSLPR interactions 
remain poorly defined (Figure 2). 
 
Initially, based on mRNA and TSLP responsiveness, TSLPR expression was thought to 
be limited to immature B cells and myeloid cells such as monocytes and DCs (Park, 
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Martin et al. 2000; Reche, Soumelis et al. 2001; Liu, Soumelis et al. 2007).  However, 
more recent work has highlighted a wider pattern of TSLPR expression as mast cells 
and human and murine CD4+ T cells are responsive to treatment with TSLP alone, or in 
conjunction with other cytokines (Allakhverdi, Smith et al. 2007; Omori and Ziegler 2007; 
Rochman, Watanabe et al. 2007; Sokol, Barton et al. 2008; Lu, Wang et al. 2009) (Table 
1).  DCs and mast cells appear to express TSLPR constitutively (Reche, Soumelis et al. 
2001; Soumelis, Reche et al. 2002; Allakhverdi, Comeau et al. 2007), however CD4+ T 
cells appear to require TCR stimulation to induce receptor expression and become 
sensitive to TSLP treatment (Al-Shami, Spolski et al. 2004; Omori and Ziegler 2007; 
Rochman, Watanabe et al. 2007; Lu, Wang et al. 2009).  As high affinity ligand binding is 
dependent upon the dimerization of the TSLPR-α chain with the IL-7R-α chain, co-
expression of CD127 must also be examined.  While lymphoid cell expression of CD127 
has been well documented and studied (Mazzucchelli and Durum 2007), DC expression 
of CD127 remains more controversial with findings varying between tissue, DC subset, 
and activation status (Guimond, Veenstra et al. 2009; Vogt, Link et al. 2009).  The recent 
development of a fluorochrome-conjugated TSLPR-α chain-specific mAb for flow 
cytometry has allowed for the investigation of TSLPR complex expression on a variety of 
cell types directly ex vivo.  Analysis of TSLPR complex expression on cells in the GALT 
will be presented in Chapter 2.   
 
Initial reports characterizing the function of TSLP on myeloid cell populations 
demonstrated that human monocytes and CD11c+ DCs were sensitive to TSLP 
treatment in vitro and were potently stimulated to produce CCL17, a known ligand for 
CCR4, which is expressed on polarized TH2 cells (Reche, Soumelis et al. 2001).  
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Further, TSLP enhanced the spontaneous maturation of blood-derived human CD11c+ 
cells, increasing their expression of co-stimulatory molecules and their ability to promote 
naïve CD4+ T cell proliferation (Reche, Soumelis et al. 2001).  The putative link between 
TSLP and TH2 cytokine responses was solidified when TSLP-treated DCs were 
demonstrated to drive IL-4, IL-5, and IL-13 production from naïve CD4+ T cells upon co-
culture (Soumelis, Reche et al. 2002).  
 
Mechanistic analysis demonstrated that TSLP-treatment of DCs induced multiple 
changes in DC function to create a permissive environment for TH2 cell differentiation.  
TSLP-treatment of human monocyte-derived DCs (mDCs) was shown to alter DC 
maturation such that the ability to upregulate major histocompatibility complex (MHC) 
class II and the co-stimulatory molecules CD80 and CD86 was preserved while DC 
cytokine production was selectively altered, thus resulting in the ability to stimulate and 
influence T cell differentiation (Soumelis, Reche et al. 2002; Rimoldi, Chieppa et al. 
2005).  TSLP-treated mDCs do not produce IL-12 and TSLP treatment of either mDCs or 
murine bone marrow-derived DCs (BMDCs) results in the inhibition of IL-12 production 
following stimulation with TLR-ligands or whole bacteria (Rimoldi, Chieppa et al. 2005; 
Zaph, Troy et al. 2007).  TSLP-treatment also induces the expression of OX40L, which 
promotes TH2 cell differentiation in the absence of IL-12 (Ito, Wang et al. 2005). The 
presence of OX40L on TSLP-treated DCs also induces production of TNF-α in TH2 cells 
(instead of IL-10), suggesting these cells may have altered functions compared to 
conventional TH2 polarized cells (Ito, Wang et al. 2005; Liu 2006; Liu 2007).  
Interestingly, treatment of human DCs activated by TSLP with the imidazoquinoline 
compound R848 was sufficient to revert the DCs to induce TH1 cell differentiation.  The 
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TH1 cell-inducing capacity of the R848 treated TSLP-DCs was dependent upon the 
induction of IL-12 expression and the repression of OX40L (Torii, Ito et al. 2008), thus 
highlighting the opposing roles of IL-12 and OX40L in TSLP-induced DC function.  
Additionally, the reversibility of the effects of TSLP on DCs upon R848 treatment 
suggests plasticity and that TSLP may not represent an overriding signal on DCs for T 
cell differentiation.  The capacity of TSLP to modulate DC and T cell-derived 
proinflammatory cytokines will be examined in Chapter 4.   
 
The ability of TSLP to promote TH2 cytokine responses is not confined to its abilities to 
influence DC function, as it is also able act on mast cells and T cells.  Human mast cells 
have been recently demonstrated to express the functional TSLPR complex, and 
following exposure to TSLP they produce the TH2 cytokines IL-5 and IL-13 as well as the 
proinflammatory cytokines IL-6 and GM-CSF (Allakhverdi, Comeau et al. 2007).  
However, it is important to note that mast cells were unable to respond to TSLP alone 
and required IL-1 or TNF-α to induce cytokine expression (Allakhverdi, Smith et al. 2007) 
suggesting that a proinflammatory environment must be present for mast cells to be 
responsive to TSLP.  Similarly, exposure to IL-33 is also able to sensitize mast cells to 
TSLP stimulation, resulting in mast cell production of IL-5, IL-13, GM-CSF, and 
enhanced production of several chemokines (Allakhverdi, Smith et al. 2007).   However, 
IL-1, TNF-α, or IL-33 in conjunction with TSLP did not result in mast cell degranulation or 
mediator release (Allakhverdi, Comeau et al. 2007; Allakhverdi, Smith et al. 2007).  
TSLP, in conjunction with either IL-1/TNF-α or IL-33, is also able to act upon CD34+ 
haematopoietic progenitor cells to induce IL-5 and IL-13 production (Allakhverdi, 
Comeau et al. 2009).   The ability of TSLP to influence CD34+ progenitor cells, which are 
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released from the bone marrow and following circulation into peripheral tissues 
differentiate into mast cells, eosinophils, or basophils indicates that TSLP may act on 
innate cells at multiple time points during TH2 cytokine-mediated inflammation. 
 
In vitro studies demonstrated that following TCR stimulation human CD4+ T cells 
upregulate TSLPR expression and become sensitive to TSLP (Rochman, Watanabe et 
al. 2007; Lu, Wang et al. 2009).  TSLP treatment of stimulated murine CD4+ T cells in 
vitro also results in the expression of IL-4 (Omori and Ziegler 2007).  Collectively, these 
reports identify several cellular targets for TSLP in vivo and provide multiple 
mechanisms for TSLP to influence both innate and adaptive immune responses.  A 
summary of known cellular targets in presented in Table 1. 
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Figure 2 TSLPR signaling pathways 
Figure 2  Downstream signaling pathways activated following TSLP receptor 
ligation.  Modified from Saenz, Taylor et al. 2008 
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Table 1 Summary of cellular sources, stimuli that induce expression, and cellular 
targets of TSLP 
 
Cellular   
sources 
Inducing  
stimuli 
Target cell  
populations 
Thymic stromal cells 
Lung ECs 
Tonsilular crypt EC 
Intestinal ECs 
Keratinocytes 
Mast cells 
Basophils 
 
TLR ligands 
Viruses 
Bacteria 
Helminth parasites 
Environmental airborne fungi 
IL-1, TNF-α 
IL-4, IL-13 
IL-25 
IL-33 
Tissue damage 
FcE cross linking 
Papain 
Trypsin 
Epidermal kallikrein (KLK5) 
Cigarette smoke extract 
 
Monocytes 
Dendritic cells 
CD4+ T cells 
CD8+ T cells 
Mast cells 
B cells 
 19 
Role of TSLP in immune system development 
Initially described as a factor able to support and promote the development of the 
NAG8/7 B cell line in vitro, TSLP was characterized as a B lymphocyte growth factor 
(Friend, Hosier et al. 1994; Sims, Williams et al. 2000).  Subsequent in vitro studies 
demonstrated that B cell precursors must differentiate to the large pre-B stage and 
express the pre-B cell receptor in order to respond to TSLP treatment (Vosshenrich, 
Cumano et al. 2003; Vosshenrich, Cumano et al. 2004).  However, in vivo studies 
utilizing TSLPR-/- mice demonstrated no role for the TSLP pathway in B lymphopoiesis.  
TSLPR-/- mice were indistinguishable from littermate control animals and had normal 
populations of B cells in adult animals (Carpino, Thierfelder et al. 2004).  Despite 
unaltered B cell development in the absence of TSLP responsiveness, systemic 
overexpression of TSLP in vivo results in altered composition and frequency of B cell 
populations (Taneda, Segerer et al. 2001; Osborn, Ryan et al. 2004; Astrakhan, Omori 
et al. 2007).  For example, targeted overexpression of TSLP in the skin increased 
circulating levels of TSLP that resulted in enhanced numbers of immature and naïve B 
cells in the periphery, loss of splenic marginal zone B cells, and increased numbers of 
peritoneal B-1b B cells (Astrakhan, Omori et al. 2007).  B cell development was also 
impacted in a TSLP-dependent manner in a study examining the importance of Notch 
signaling in maintaining epidermal integrity in mice.  Demehri et al. demonstrated that 
successive loss of Notch signaling specifically in the epidermis results in increased 
serum levels of TSLP, and that the increase in TSLP production was responsible for the 
lethal B-lymphoproliferative disorder observed in these mice (Demehri, Liu et al. 2008).  
While there was no evidence suggesting direct regulation of TSLP by Notch in epithelial 
cells, the authors link the heightened TSLP production to the inability to form fully 
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differentiated keratinocytes capable of barrier formation (Demehri, Liu et al. 2008).  
Similar to the skin transgenic model, the mice with heightened TSLP exhibited greatly 
expanded pre- and immature B cell compartments in the periphery (Demehri, Liu et al. 
2008).  Taken together, these data suggest that while TSLP is dispensable for B 
lymphopoiesis under normal conditions, excess production of TSLP can influence B cell 
development in vivo.   
 
Despite the similarity of TSLP to IL-7 and the TSLPR chain to the γc, the TSLP-TSLPR 
pathway does not seem to be strictly required for T cell development.    Examination of 
TSLPR-/- mice revealed normal T cell lymphopoiesis and normal T cell populations in 
adult mice (Carpino, Thierfelder et al. 2004).  However, increased lymphoid defects seen 
in γc/TSLPR double deficient over γc single deficient mice and the ability of transgenically 
overexpressed TSLP to restore lymphoid development in IL-7 deficient mice indicate that 
TSLP maintains the ability to support or promote T cell lymphopoiesis (Al-Shami, Spolski 
et al. 2004; Chappaz, Flueck et al. 2007).  In vitro, TSLP was demonstrated to increase 
thymopoiesis in murine fetal thymic organ culture (Jiang, Coffield et al. 2007).  Further, 
TSLP appears to influence the proliferative capacity of CD4+ T cells, as addition of TSLP 
to TCR stimulated CD4+ T cells in vitro resulted in increased cell division (Al-Shami, 
Spolski et al. 2004).  TSLP acting on DCs may also play a role in CD4+ T cell 
homeostasis as TSLP-treated DCs stimulated increased expansion of autologous CD4+ 
T cells compared to control DCs (Watanabe, Hanabuchi et al. 2004).  Additionally, CD4+ 
T cells from TSLPR-/- mice expand less efficiently than WT CD4+ T cells in irradiated 
hosts (Al-Shami, Spolski et al. 2004).  Thus, similar to B cell development, TSLP is not 
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critical for T lymphopoiesis under normal conditions but alterations in its availability may 
impact T cell development or optimize T cell expansion under certain circumstances.    
 
Thymic expression of TSLP has been demonstrated to function in DC activation and 
regulatory T cell (Treg) development. Expression of TSLP within the epithelial cells of 
the Hassal’s corpuscles region of the human thymic medulla correlates with DC 
activation and the subsequent positive selection of high-affinity self-reactive Tregs 
(Watanabe, Wang et al. 2005).  Although mice lack the Hassal’s corpuscle structure 
within the thymus, there is evidence to support a potential role for murine TSLP in the 
direct promotion of Treg development.  Supplementation of TSLP within fetal thymic 
organ cultures increased expression of FoxP3 and culture of thymocytes with TSLP 
promoted the differentiation of CD4+CD25+FoxP3+ cells (Jiang, Su et al. 2006; Lee, Lim 
et al. 2008).  Depletion of IL-7 in the presence or absence of TSLPR was shown to 
produce a more severe defect in Treg development in the thymus when mice were 
lacking both IL-7 and TSLPR (Mazzucchelli, Hixon et al. 2008).  These results suggest 
that TSLP and IL-7 may have some redundant and/or overlapping function in thymic 
Treg development. 
 
In addition to influencing thymic Treg development, TSLP has also been proposed to 
influence peripheral conversion of naïve CD4+ T cells to FoxP3+ Treg cells.  Studies 
found that TSLP-treated DCs co-cultured in vitro with total splenic CD4+ T cells 
increased the frequency of CD4+CD25+FoxP3+ T cells compared to either unstimulated 
or LPS-stimulated DCs (Besin, Gaudreau et al. 2008).  Further, in vitro work using 
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human epithelial cells indicate that IEC-derived TSLP may be important for optimal 
peripheral conversion of CD4+ T cells into FoxP3+ Tregs (Iliev, Spadoni et al. 2009). 
 
Despite these findings, the relative importance of TSLP influencing either natural or 
adaptive Treg populations in vivo remains controversial.  Examination of TSLPR-/- mice 
found normal numbers of circulating CD4+CD25+FoxP3+ Tregs (Sun, Hall et al. 2007), 
indicating that TSLP is not essential for the development of natural Tregs. Additionally, 
analysis of surface marker expression on developing CD4+FoxP3+ Tregs in the thymus 
failed to show TSLPR-α chain expression, and these cells did not phosphorylate STAT-5 
in response to TSLP stimulation (Vang, Yang et al. 2008).  Further, lamina propria DCs 
isolated from TSLPR-/- mice did not exhibit any defect in mediating FoxP3 Treg 
conversion in vitro (Sun, Hall et al. 2007), suggesting that TSLP is also not required for 
adaptive Treg development in the periphery.  Studies focusing on mature Treg cell 
survival in the periphery also failed to define a role for peripheral Treg homeostasis 
(Mazzucchelli, Hixon et al. 2008).  Taken as a whole, these finding suggest that TSLP is 
not essential for B or T cell lymphopoiesis or the development/selection/maintenance of 
CD4+FoxP3+ Tregs in vivo.  However, TSLP may be able to modulate these processes in 
cases of increased or altered availability.   
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Functional biology of TSLP in the skin and lung 
TSLP was first associated with dysregulated TH2 cytokine production in the human 
disease of atopic dermatitis.  Skin biopsies from atopic dermatitis lesions showed greatly 
enhanced levels of TSLP compared to non-lesion biopsies (Soumelis, Reche et al. 
2002).  Heightened TSLP expression was also detected in the airways of asthmatic 
patients and correlated with disease severity (Ying, O'Connor et al. 2005).  A more 
causal relationship between TSLP and TH2 cytokine-mediated disease was established 
with transgenic over-expression models.  Targeted overexpression of TSLP in epithelial 
cells of the skin or lung results in the development of severe TH2-cytokine mediated 
inflammation resembling atopic dermatitis and asthma, respectively (Li, Messaddeq et 
al. 2005; Yoo, Omori et al. 2005; Zhou, Comeau et al. 2005).  In both tissues, the 
increased expression of TSLP resulted in the development of CD4+ TH2 cells, 
inflammatory cell infiltration, eosinophil infiltration, increased IgE production, and tissue 
damage.  The CD4+ TH2 cells that developed were highly polarized, producing high 
levels of IL-4 with little to no IFN-γ production being detected (Li, Messaddeq et al. 2005; 
Yoo, Omori et al. 2005; Zhou, Comeau et al. 2005).    
 
The link between increased TSLP expression and disease has also been strengthened 
by the phenotype of transgenic mice whose gene alterations lead to the dysregulated 
overproduction of TSLP.  Mice lacking nuclear hormone receptor retinoid X receptor 
(RXR) isotypes RXR-α and RXR-β expression specifically in keratinocytes have 
significantly increased production of TSLP and develop a TH2 cytokine-mediated chronic 
dermatitis that mirrors human atopic dermatitis (Li, Messaddeq et al. 2005).  Further, 
application of topical vitamin D3 and other agonists for the RXR-α and RXR-β signaling 
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pathways lead to increased TSLP expression and in turn severe chronic dermatitis (Li, 
Hener et al. 2006).  Consistent with the connection between dysregulated TSLP 
production and atopic disease, mice lacking responsiveness to TSLP (TSLPR-/-) mice 
are less susceptible to an OVA-induced model of allergic asthma.  In this model, TSLPR-
/- animals failed to produce TH2 cell-associated cytokines and did not exhibit lung 
inflammation (Al-Shami, Spolski et al. 2005; Zhou, Comeau et al. 2005).   
 
The expression of TSLP is largely restricted to barrier surfaces and it has been proposed 
that TSLP acts primarily in the microenvironment surrounding its site of production.  
While tissue-specific overexpression of TSLP in the lung resulted in increased levels of 
circulating total IgE, for example, the inflammatory response was predominately 
restricted to the lung.  Activated, cytokine producing CD4+ T cells isolated from this site 
expressed the skin/lung homing marker CCR4.  Furthermore, while CD4+ IL-4+ cells 
were detectable in the lung and draining lymph nodes, few cytokine positive cells were 
detected in peripheral lymph nodes (Zhou, Comeau et al. 2005).  
 
While TSLP appears to primarily act within its localized microenvironment under 
physiological conditions, heightened systemic levels of TSLP have been demonstrated 
to alter systemic immune responses.  For instance, examination of the K5-TSLP or K14-
TSLP transgenic mice, which despite being under keratinocyte-specific promoters have 
overproduction of TSLP with high levels of circulating TSLP detected in the serum 
(Astrakhan, Omori et al. 2007; Chappaz, Flueck et al. 2007), revealed altered systemic 
immune responses.  These mice display increased serum levels of IL-5 and elevated 
numbers of circulating eosinophils (Li, Messaddeq et al. 2005), as well the presence of 
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IL-4-producing CD4+ T cells in non-skin draining lymph nodes (Zhou, Comeau et al. 
2005).  Further, repeated intradermal injection of recombinant TSLP into WT mice 
induces increased levels of serum IgE and IgG1 (Jessup, Brewer et al. 2008).  
Additionally, studies investigating the link between atopic dermatis and the 
predisposition to the development of asthma (also known as the “atopic march”) have 
found that keratinocyte-derived systemic levels of TSLP increased the severity and 
onset of experimental asthma (Demehri, Morimoto et al. 2009; Zhang, Hener et al. 
2009).  Taken together, these findings suggest that increased production of TSLP 
extends its influence beyond barrier surfaces and may lead to predisposition of the host 
to multiple TH2 cytokine-mediated pathologies. 
 
Given the ability of TSLP to influence DC responses in vitro, TSLP may target DCs to 
modulate localized immune responses.  Either skin or lung resident DCs could become 
conditioned or activated by locally produced TSLP, migrate to the draining lymph node, 
initiate TH2 cell differentiation, and imprint on the T cells the proper receptors to return to 
sites of inflammation.  The expression of TSLPR on activated CD4+ T cells also raises 
the possibility that TSLP could act directly on infiltrating CD4+ T cells to promote TH2 cell 
development.  These possibilities are not mutually exclusive, however, and the ability of 
DCs to produce the TH2 cell attracting chemokines, CCL17 and CCL22, may also act to 
help initiate and/or promote local TH2 cytokine responses.  However, as DC responses in 
vivo have not been examined directly in any of the existing literature and cell-specific 
TSLPR-/- mice have not been reported, it remains uncertain as to which cells TSLP is 
acting on in vivo to initiate TH2-cytokine mediated inflammation.   
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Although it remains unclear which cells TSLP targets in vivo during allergic responses, 
evidence exists to suggest that an innate cell component is also involved.  In the K5-
TSLP skin transgenic model, the contribution of T cells to the inflammatory phenotype 
was determined by generating K5-TSLP transgenic mice that were also T cell deficient.  
In the absence of T cells, immune pathology still developed and inflammatory cell 
infiltration was observed (Yoo, Omori et al. 2005).  Also, RAG-/- mice treated on the ear 
with the vitamin D3 low-calcemic analog MC903, which is known to induce TSLP 
production and atopic dermatitis, still developed epidermal hyperplasia and dermal cell 
infiltrate including increased numbers of eosinophils, mast cells, and dermal dendritic 
cells (Li, Hener et al. 2006).  Thus, treatment with MC903 is able to induce TSLP 
expression in the absence of adaptive immune cells, and mature B and T cells are also 
not required for the induction of MC903-mediated inflammation in the ear (Li, Hener et 
al. 2006).  Given the ability of TSLP, in the context of either TNF-α or IL-1, to induce 
mast cell cytokine production (Allakhverdi, Smith et al. 2007) it is possible that mast cells 
play a dynamic role in either initiating or perpetuating the inflammation caused by TSLP 
overexpression.  However, studies utilizing intradermal injection of recombinant TSLP 
into RAG-/-, athymic nude mice, mast cell deficient mice (KitW-sh), and eosinophil deficient 
mice (ΔdblGATA), highlighted the importance of T cells and eosinophils in the 
development of TSLP-mediated skin inflammation while suggesting that mast cells 
played a non crucial role (Jessup, Brewer et al. 2008).   It is clear that more work is 
required to determine whether innate cells play a role in either the initiation or the 
maintenance of TSLP-mediated inflammation in the skin, and whether these roles are 
conserved in other tissue sites of TSLP-mediated inflammation such as the lung.   
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While reports of TSLP-induced TH2 cytokine-mediated diseases have been largely 
restricted to the skin and the lung, there are new reports emerging that TSLP may play a 
role in the pathogenesis of other allergic diseases.  Increased TSLP expression has 
been reported in the nasal epithelium in a mouse model of allergic rhinitis and 
neutralization of TSLP using a monoclonal anti-TSLP antibody inhibited the development 
of disease (Miyata, Hatsushika et al. 2008).  Also, increased TSLP expression has been 
documented in the synovial fluid of arthritic joints of human patients with rheumatoid 
arthritis (Koyama, Ozawa et al. 2007). 
 
TSLP in the intestine 
Although TSLP expression in the skin and the lung has been linked to pathologic TH2 
cytokine-mediated responses, TSLP expression in the intestine appears to play an 
important role in protective host immunity.  Recent work has highlighted the importance 
of IECs in influencing immune cell homeostasis and immunity to helminth parasites 
(Rimoldi, Chieppa et al. 2005; Nenci, Becker et al. 2007; Zaph, Troy et al. 2007).  IEC-
specific deletion of IKKβ resulted in susceptibility to the intestinal dwelling nematode 
Trichuris and was correlated to decreased expression of TSLP (Zaph, Troy et al. 2007).  
Despite being on a genetically resistant background, TSLPR-/- mice challenged with 
Trichuris failed to clear worms at day 21 post-infection and produced the non-protective 
TH1 cytokine IFN-γ (Zaph, Troy et al. 2007).  The strong induction of TSLP mRNA upon 
infection (Humphreys, Xu et al. 2008), and its requirement for efficient early worm 
clearance (Zaph, Troy et al. 2007), indicate that TSLP is a critical component of 
protective TH2 cytokine-mediated immune responses in the intestine.   
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Despite these advances in the understanding of the potential role of TSLP-TSLPR 
interactions in the intestine, many basic questions remain undefined and will form the 
focus of this thesis research.  Chapter 2 will be dedicated to defining and characterizing 
the cellular sources and targets of TSLP in the GALT and large intestine under naïve, 
homeostatic conditions.  Chapter 3 will explore the requirement for TSLP in the 
generation of a host-protective TH2 cytokine-mediated immune response to the intestinal 
helminth pathogen Trichuris muris.  Finally, Chapter 4 will investigate the potential of 
TSLP to regulate proinflammatory cytokine production in the intestine.   
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Figure 3 TSLP promotes TH2 cytokine responses 
Figure 3 TSLP promotes TH2 cytokine responses.  Epithelial cell-derived TSLP (1) 
can act to promote TH2 cytokine responses through interactions with DCs (2), 
naïve CD4+ T cells (3), and granulocyte populations (4).   
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Model Systems  
Trichuris muris 
Life cycle and transmission 
Trichuris muris is a gastrointestinal nematode pathogen of mice that is commonly utilized 
to model the human whipworm pathogen, Trichuris trichiura (Cliffe and Grencis 2004).  
T. muris transmission occurs through the ingestion of infective eggs present in fecal 
contamination.  It is thought that the embryonated eggs hatch in the cecum (Panesar 
and Croll 1980), and L1 larvae can be detected within the cecum within hours of 
infection (Wakelin 1967).  Larvae enter into the mucosal tissue of the large intestine 
living within the epithelial cell layer, never penetrating through the basement membrane 
into the lamina propria (Lee and Wright 1978; Tilney, Connelly et al. 2005).  Larvae 
undergo a series of four molts, reaching sexual maturity and adulthood after the fourth 
molt occurring on day thirty-two (Cliffe and Grencis 2004).  The anterior end of the worm 
remains embedded within the epithelial cell layer; scanning and transmission electron 
micrograph studies have revealed that the worm creates syncitial tunnels within 
intestinal epithelial cells (Lee and Wright 1978).  Though the anterior head of the worm 
remains burrowed within the epithelial cell layer of the large intestine throughout the life 
cycle, the body of the worm extends freely into the lumen of the intestine and in 
adulthood can be visualized by the naked human eye.  The extension of the body of the 
worm outside of the epithelial cell layer permits copulation (Panesar and Croll 1980).  
The life cycle is completed when following mating the female worm releases eggs into 
the intestine, which are then shed within the feces of the host.   The eggs must then 
embryonate over a period of several months to become infective (Cliffe and Grencis 
2004) (Figure 4A).  
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Public health impact 
An estimated two billion individuals worldwide are infected with soil-transmitted 
helminths (Colley, LoVerde et al. 2001; WHO 2009).  Recent studies have estimated the 
global prevalence of Trichuris trichiura at 604 million with an additional 3.2 billion 
individuals at risk of infection (de Silva, Brooker et al. 2003; Bethony, Brooker et al. 
2006).  Children remain especially susceptible to infection and other risk factors include 
living within a tropical climate, and poor sanitation (Hotez, Molyneux et al. 2007).   
Currently, developing regions of Asia, Africa and Latin America have the highest rates of 
Trichuris trichiura infection, with the highest incident rates being focused in areas of rural 
poverty (Hotez, Brindley et al. 2008) 
 
While trichuriasis itself is rarely fatal, clinical manifestations of the disease range from 
impaired nutritional status, growth retardation, and lower educational achievement 
(Callender, Grantham-McGregor et al. 1992; Nokes, Grantham-McGregor et al. 1992; 
Nokes and Bundy 1994) to the more severe protein-losing enteropathy, chronic 
dysentery, anemia, and rectal prolapse (Symons 1969; Bundy and Cooper 1989; 
Grencis and Cooper 1996; Albonico, Crompton et al. 1999).  Additionally, 1.6 - 6.4 
million disability-adjusted life years (DALY) are attributed to trichuriasis (Hotez, Fenwick 
et al. 2009) indicating a substantial disease burden.  Treatment with the anti-helminth 
drugs albendazole or mebendazole is effective to induce the expulsion of the infective 
worms (Hotez, Brindley et al. 2008), however the procurement and distribution of these 
drugs  remains an issue in the global fight to eradicate trichuriasis (Hotez, Fenwick et al. 
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2009).  The World Health Organization (WHO) estimates that less than half of the drugs 
needed to treat trichuriasis globally are currently available (WHO 2008).   
 
Trichuris muris as a model of protective TH2 cytokine-dependent immune responses 
Investigation into Trichuris muris infection began as early as 1940 (Shikhobalova 1940) 
but it was not until the 1960s that the importance of the immune response to infection 
was appreciated (Campbell 1963; Wakelin 1967).  Studies comparing Trichuris muris 
infection across multiple mouse strains also revealed a host genetic component to 
resistance, as worm expulsion varies between strains, with some strains demonstrating 
resistance to infection and others failing to expel the worms and remaining chronically 
infected for the lifetime of the host (Wakelin 1975).  Although variation exists between 
strains, the peak of the effector immune response in genetically-resistant mice is at day 
21, and mice expel their worms between days 18-24 with complete clearance by day 32 
post-infection. 
 
CD4+ T cells are required for immunity to Trichuris muris.  Adoptive transfer studies 
demonstrated that transfer of CD4+ T cells into severe combined immunodeficient mice 
(SCID) was sufficient to mediate resistance to infection (Else and Grencis 1996).  
Antibody-mediated depletion studies have demonstrated that immunity to infection can 
occur in the absence of CD8+ T cells (Koyama, Tamauchi et al. 1995).  B cells also do 
not appear to be required for host resistance in an intact animal.  Trichuris-infected SCID 
mice lacking all B and T lymphocytes were able to clear infection with the transfer of 
CD4+ T cells alone (Else and Grencis 1996).   Additionally, µMT mice, which are 
deficient in B cells, displayed intact TH2 cytokine-mediated host-protective immunity 
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(Perrigoue, Saenz et al. 2009).  Thus while CD8+ T cells and B cells may contribute to 
resistance within an intact animal, worm expulsion and immunity can occur in their 
absence. 
 
Subsequent studies analyzing the role of CD4+ T cells in infection have revealed that 
immunity to Trichuris muris is critically dependent on the generation of CD4+ TH2 cells 
(reviewed in (Abbas, Murphy et al. 1996; O'Garra 1998; Murphy and Reiner 2002)) and 
the production of IL-4, IL-9, and IL-13 (Else, Entwistle et al. 1993; Else, Finkelman et al. 
1994; Koyama, Tamauchi et al. 1995; Else and Grencis 1996) (Figure 4B).  TH2 cytokine 
production in the intestine is associated with a number of physiologic changes that 
correlate with worm expulsion, including mastocytosis, eosinophilia, smooth muscle 
contraction and changes in epithelial cell turnover, all of which have been implicated in 
expulsion of multiple helminth parasites (reviewed in (Finkelman, Shea-Donohue et al. 
1997; Grencis 1997; Anthony, Rutitzky et al. 2007).  However, mastocytosis and 
eosinophilia are not required for immunity to Trichuris muris infection, as either genetic 
or antibody-mediated depletion of these cell subsets failed to alter worm expulsion (Betts 
and Else 1999; Koyama and Ito 2000).  Instead, parasite expulsion is correlated to TH2 
cytokine-induced goblet cell hyperplasia and the production of goblet cell-specific factors 
such as RELMβ and Gob5 (Zhou, Dong et al. 2001; Artis, Wang et al. 2004; Zaph, Troy 
et al. 2007), smooth muscle hypercontractility (Khan, Richard et al. 2003), and increased 
epithelial cell turnover (Cliffe, Humphreys et al. 2005). 
 
In contrast to TH2 cytokine-dependent resistance, susceptibility to infection is 
characterized by the development of CD4+ TH1 cells (reviewed in (Abbas, Murphy et al. 
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1996; O'Garra 1998; Murphy and Reiner 2002) and is critically associated with the 
production of IL-12 and IFN-γ (Else, Hultner et al. 1992; Else, Entwistle et al. 1993; Else, 
Finkelman et al. 1994) (Figure 4B).  In fact, in vivo antibody-mediated depletion of IFN-γ 
in susceptible strains of mice is sufficient to induce resistance and worm expulsion (Else, 
Finkelman et al. 1994).  Conversely, administration of recombinant IL-12 to genetically 
resistant strains of mice results in susceptibility and chronic infection (Bancroft, Else et 
al. 1997).   
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Figure 4 Trichuris muris life cycle and immune response 
Figure 4 Life cycle and immune regulation of Trichuris muris infection.  (A) Eggs 
are ingested orally and hatch in the cecum (1).  Larval parasites then invade IECs 
that line the crypts of the cecum and proximal colon (2), where they undergo four 
molts to become sexually mature adults and release eggs into the environment (3, 
4).  (B) Different Trichuris-specific immune responses determine resistance and 
susceptibility to infection in inbred mice.  TH1 associated cytokines (IL-12, IFN-γ) 
promote chronic infection in AKR mice, while TH2 associated cytokines (IL-2, IL-9, 
IL-13) promote larval expulsion and immunity in resistant strains such as C57/BL6, 
and Balb/c. 
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Dextran Sulfate Sodium (DSS) colitis: a murine model of inflammatory bowel 
disease (IBD) 
IBD: Disease and public health impact 
IBD in humans comprises multiple pathologies and disorders, the two main forms being 
Crohn’s disease and ulcerative colitis (Cho 2008).   Both diseases present with systemic 
symptoms such as weight loss, fever, and fatigue as well as gastrointestinal symptoms 
ranging from abdominal pain and diarrhea to rectal bleeding (Strober, Fuss et al. 2007).  
Clinical onset generally occurs between age 20-30 and both diseases are characterized 
by their chronic and relapsing nature (Cobrin and Abreu 2005; Xavier and Podolsky 
2007).  Disease incidence is generally low in developing nations, with substantially 
higher disease rates in first world countries (Gismera and Aladren 2008).  It is estimated 
that between 7,000 - 46,000 cases of ulcerative colitis and 10,000 - 47,000 cases of 
Crohn’s diseases are newly diagnosed each year in North America alone (Loftus 2004).  
The increasing disease rates in developed nations indicate a role for environmental 
factors in driving IBD (Xavier and Podolsky 2007; Gismera and Aladren 2008).  
Genome-wide screens have also identified a genetic component to IBD susceptibility 
with multiple IBD-susceptibility loci being identified.  These loci include immune 
response genes, with mutations in the genes encoding the bacterial sensing protein 
NOD2 and the IL-23 receptor complex being inked to increased incidence of Crohn’s 
disease (Xavier and Podolsky 2007). 
 
While Crohn’s disease and ulcerative colitis present with similar symptoms, they are 
separate diseases.  Crohn’s disease may target any section of the gastrointestinal tract 
and is characterized histopathogically by transmural inflammation, macrophage 
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aggregation, and the presence of non-caseating granulomas (Xavier and Podolsky 
2007).  In contrast, ulcerative colitis is restricted to the large intestine and results in 
extensive superficial ulceration with depletion of goblet cell-derived mucin, neutrophilia in 
the lamina propria, and micro-abscesses in the crypt (Xavier and Podolsky 2007).  
Immunologically, the pathology associated with Crohn’s disease is characterized by 
increased production of IL-12, IL-23, IFN-γ, and IL-17, while ulcerative colitis is 
associated with excess IL-13 production (Strober, Fuss et al. 2007).   
 
Although the exact etiology of IBD remains poorly defined, there is strong evidence to 
suggest that inappropriate immune responses to innocuous commensal bacteria help to 
drive disease (Strober, Fuss et al. 2007; Xavier and Podolsky 2007; Cho 2008; Round 
and Mazmanian 2009).  Increased barrier permeability is associated with disease, and 
subsets of patients respond to antibiotic therapy (Xavier and Podolsky 2007).  
Additionally, multiple murine models of IBD are ameliorated if animals are either raised 
in germ-free conditions or treated with antibiotics (Round and Mazmanian 2009).  
Further, while it is difficult to determine cause versus effect, patients with IBD have 
altered commensal flora compared to healthy control subjects (Frank, St Amand et al. 
2007). 
 
DSS colitis: A chemical-induced experimental colitis model 
Dextran sulfate sodium (DSS) is a 30 - 50 kDa polyanionic derivative of dextran that 
when administered orally at concentrations between 3 – 10% in the drinking water 
induces colitis in mice (Okayasu, Hatakeyama et al. 1990).   DSS is thought to be toxic 
to IECs (Kitajima, Takuma et al. 1999), and induces IEC damage and increased barrier 
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permeability (Kitajima, Takuma et al. 1999).  DSS-colitis presents with weight loss, 
alterations in fecal consistency, rectal bleeding, and increases in mouse morbidity 
(Okayasu, Hatakeyama et al. 1990).  Histopathologically, DSS colitis is characterized by 
colonic shortening, immune cell recruitment, neutrophilic infiltration, loss of crypt 
architecture, goblet cell hypoplasia, and the formation of focal ulcerations (Okayasu, 
Hatakeyama et al. 1990; Melgar, Karlsson et al. 2005).   
 
Lymphocytes do not appear to be required for the onset of colitis, as DSS-treated SCID 
mice still develop disease (Dieleman, Ridwan et al. 1994).  However, lymphocytes are 
recruited to the site of inflammation and produce cytokines that contribute to the 
maintenance and severity of disease.  For example, RAG-1 deficient mice exhibited 
reduced disease symptoms and severity compared to WT mice following treatment with 
1.5% DSS (Kim, Seo et al. 2006).  Acute colitis is characterized by CD4+ T cell 
production of IFN-γ; however, if the colitis is allowed to progress and become chronic 
both TH1 and TH2 CD4+ T cells are present (Dieleman, Palmen et al. 1998).  The 
proinflammatory cytokines TNF-α, IL-6, and IFN-γ are though to contribute to tissue 
damage (Strober, Fuss et al. 2002).  However, more recent work has also indicated an 
important role for IL-23 and IL-17 (Ogawa, Andoh et al. 2004). 
 
Conclusion 
Together Trichuris muris infection and DSS-induced colitis provide relevant model 
systems in which the importance of TSLP-TSLPR interactions in the intestine can be 
assessed in vivo.  Chapter 3 of this thesis will employ the Trichuris muris infection model 
to explore the requirement for TSLP-TSLPR interactions in the generation of a host-
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protective TH2 cytokine response in the intestine.  The DSS colitis model will be used in 
Chapter 4 to examine the ability of TSLP to influence intestinal proinflammatory cytokine 
production and inflammation. 
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CHAPTER 2: Characterization of TSLP-TSLPR expression in the 
gastrointestinal lymphoid tissues (GALT) 
 
Abstract 
While TSLP-TSLPR interactions have been shown to influence intestinal immune 
homeostasis, to date the cellular sources and targets of TSLP in the GALT and the large 
intestine have not been comprehensively analyzed.  We found that under resting steady 
state conditions, IECs from WT naïve mice constitutively express TSLP at both the 
mRNA and protein level in the cecum and large intestine.  Analysis of surface co-
expression of TSLP-α chain and CD127, which form the functional TSLPR complex, 
found TSLPR complex to be expressed on splenic and GALT CD11c+ DCs, irrespective 
of DC subset or activation status.  In vitro studies utilizing BMDCs found the TSLPR-α 
chain to be dynamically upregulated by externally-derived factors and a variety of host-
derived cytokines.  Additionally, TSLPR complex expression was exhibited by mast cells 
and basophils in the spleen and by CD3+ CD4+ T cells in the spleen and GALT.  
Functionality of receptor expression was assessed by direct ex vivo stimulation of 
splenoctye or MLN cultures with rTSLP.  We found that both splenic and MLN CD11c+ 
DCs and CD4+ T cells responded to TSLP and upregulated phopho-STAT5.  Collectively 
these results identify potential cellular targets of TSLP-TSLPR interactions in the 
intestine and highlight the ability of TSLP to influence components of both the innate and 
adaptive immune system. 
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Introduction 
TSLP was originally isolated and identified as a product of the thymic stromal cell clone 
Z210R.1, which induced the proliferation of the nonadherent B lymphoid cell line NAG8/7 
(Friend, Hosier et al. 1994). Subsequent work utilizing cDNA libraries from different cells, 
cell lines, or purified primary cells demonstrated TSLP to be most highly expressed in 
the skin and lung (Soumelis, Reche et al. 2002).  Although TSLP mRNA expression was 
noted in the small intestine during initial characterization studies (Sims, Williams et al. 
2000), Rimoldi et al. were the first to demonstrate expression of TSLP protein in the 
large intestine.   Their work identified a role TSLP in the maintenance of intestinal 
immune homeostasis through the preferential promotion of TH2 cell differentiation 
(Rimoldi, Chieppa et al. 2005).  However, the expression pattern of TSLP throughout the 
different microenvironments of the intestinal tract remains poorly defined. 
 
While both chains of the heterodimeric TSLPR have been previously defined (Park, 
Martin et al. 2000), detection of cells expressing the unique TSLPR-α chain has been 
limited by lack of a reliable monoclonal antibody (mAb) to detect cellular expression by 
flow cytometry.  Initial experiments utilizing binding studies identified macrophages and 
monocytes as having high binding affinities (Park, Martin et al. 2000).  These results 
were confirmed and expanded to include CD11c+ DC as having high levels of expression 
of TSLPR, using TSLPR mRNA levels as a surrogate for surface expression (Reche, 
Soumelis et al. 2001).  Expression of TSLPR on DCs was shown to be functional as 
TSLP potently activates human monocyte-derived DCs, upregulating surface expression 
of co-stimulatory molecules such as CD80 and CD86 and inducing the production of the 
chemokines CCL17 and CCL22 (Reche, Soumelis et al. 2001; Soumelis, Reche et al. 
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2002).  Functional readouts such as activation of cytokine production have also identified 
mast cell and CD4+ T cell expression of TSLPR (Allakhverdi, Comeau et al. 2007; Omori 
and Ziegler 2007; Rochman, Watanabe et al. 2007).  Despite these advances in 
identifying possible cellular targets of TSLP, the majority of these studies were 
conducted in vitro on cultured cells. For example, although purified naïve CD4+ T cells 
maintained in short term culture have been shown to be responsive to TSLP (Omori and 
Ziegler 2007), the expression of TSLPR on  CD4+ T cells taken directly ex vivo has not 
been assessed.  Thus, the cellular targets of TSLP in vivo remain largely unknown; 
further it is not clear whether the cellular expression pattern of the TSLPR complex is 
altered or influenced by tissue specific environments.  In this chapter, we characterize 
for the first time the expression of both TSLP and the TSLPR complex within the GALT 
and large intestine.  We demonstrate constitutive production of TSLP mRNA and protein 
in large intestine IECs.  Further, our findings identify TSLPR complex expression on 
DCs, mast cells, basophils, and CD4+ T cells isolated from naïve WT mice.   
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Materials and Methods 
Animals 
Wild type C57BL/6 mice were obtained from Jackson Laboratories (Bar Harbor, ME).  
TSLPR+/+ and TSLPR-/- mice were obtained from Dr. James Ihle at St. Jude’s Children’s 
Hospital, Nashville TN.  Mice were bred and maintained in a specific-pathogen free 
environment at the University of Pennsylvania.  Animal protocols were approved by the 
University of Pennsylvania Institutional Animal Care and Use Committee (IACUC) and all 
experiments were carried out following the guidelines of the University of Pennsylvania 
IACUC.  
 
Parasites and antigens 
Trichuris muris was maintained in genetically susceptible animals (Wakelin 1967; 
Wakelin 1969); isolation of Trichuris excretory-secretory (ES) antigen (Ag) and eggs was 
carried out as previously described (Artis, Villarino et al. 2004).   
 
Isolation and preparation of cells 
At necropsy, spleen, MLN, cecal patch, peyer’s patch, were harvested and single-cell 
suspensions were prepared in complete T cell medium (CTCM) (DMEM supplemented 
with 10% heat-inactivated FBS, 2mM glutamine, 100 U/ml penicillin, 100 µg/ml 
streptomycin, 25mM HEPES, and 5 x 10-5 M 2-ME).  If dendritic cells were to be 
examined, tissues were first minced and incubated in 5 mls of digestive enzyme solution 
(0.5 mg/ml collagenase and 0.05% DNAse in CTCM) for 25 minutes at 37 °C while 
shaking prior to the creation of single-cell suspensions.   
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Isolation of intraepithelial and lamina propria lymphocytes 
At necropsy, small intestine and large intestine were removed and put into separate 
Petri-dishes with pre-warmed CTCM.  Cecal patch and Peyer’s patches were removed 
and placed in 2 mls CTCM on ice.  Intestines were cut longitudinally and feces were 
removed by shaking in a large Petri dish of PBS.  Intestines were further cleaned and 
mucus removed by shaking in a clean Petri dish until PBS remained clear.  Intestines 
were then cut into small sections and placed in 20 mls prewarmed epithelial strip buffer 
(1mM EDTA, 1 mM DTT, 5% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml 
streptomycin) and incubated for 20 minutes at 37 °C while shaking.  Tissue was allowed 
to settle and supernatant was filtered through a cell strainer for isolation of intraepithelial 
lymphocytes (IELs).  Purification of IELs was conducted though utilization of a Percoll 
gradient.  Briefly, cells were resuspended in 5 mls of 40% Percoll, underlayed with 70% 
Percoll, and the spun for 20 minutes at 600 g with the brake removed.  Cells were then 
pipetted from the interface and washed twice with CTCM, before resuspending in final 
volume.  For isolation of lamina propria lymphocytes (LPLs), intestines were washed 
with serum-free media 3 times, and then minced using a razor blade in a small Petri 
dish.  Intestines were then resuspended in 15 mls of digestive enzyme solution (0.5 
mg/ml collagenase and 0.05% DNAse in CTCM) and incubated for 30 minutes 37 °C 
while shaking.  The entire contents of each tube were then filtered through a cell 
strainer, and intestines were mashed in the cell strainer using the back end of a 3 ml 
syringe.  The strainers were then washed with 15 mls CTCM.  Cells were then pelleted 
and washed with CTCM before the Percoll purification was preformed as described 
above.   
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Flow cytometry and intracellular cytokine staining 
For ex vivo surface staining, cells were washed in PBS and stained with the fixable aqua 
blue viability dye (Invitrogen) to assess viability.  Cells were then washed and stained 
with fluorochrome-conjugated antibodies against CD3, CD19, CD4, CD8α, CD11c, 
CD11b, CD103, Gr-1, FcεRI, ckit, CD49b (DX5), CD127, and TSLPR.  Cells were 
analyzed by flow cytometry on a FACS Canto II using CellQuest Pro software (BD 
Pharmingen); further analysis was then carried out using FlowJo software (Treestar, 
Inc.).  For phospho-STAT5 staining, cells were rested overnight in 2% fetal bovine 
CTCM at 37 °C.  Cells were then stimulated with rTSLP (final concentration 100 ng/ml) 
for various amounts of time at 37 °C.  Cells were fixed for 10 minutes at 37 °C by adding 
in 16% PFA for a final concentration of 2%.  Cells were then washed with PBS and 
permeabilized for 30 minutes on ice with the addition of 1 ml of 90% ice-cold methanol.  
Following permeabilization, cells were washed twice with FACs buffer and stained for 1 
hour at room temperature with fluorochrome-conjugated antibodies against CD4, CD11c, 
and Phospho-STAT5 (BD Pharmingen).  Cells were then analyzed by flow cytometry as 
described above.   
 
Bone marrow-derived dendritic cells 
Bone marrow derived-dendritic cells (BMDCs) were derived as follows.  Bone marrow 
from WT C57BL/6 mice was plated in 6 well cell culture plates in RPMI 1640 
supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 5 x 10-5 M 2-ME, 10% 
FBS, 2mM L-glutamine, and 20 ng/ml GM-CSF (Peprotech).  Media was changed at 
days 3, 6 and 8; cells were harvested at day 9.  BMDCs were plated out at 4 x 106 
cells/ml and mixed 1:1 with either media alone, LPS (final concentration 100 ng/ml), CpG 
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(final concentration 10 µg/ml), Trichuris ES antigen, S. mansoni egg antigen, papain 
(final concentration 50ng/ml), IL-4 (final concentration 40 ng/ml), IFN-γ (final 
concentration 100 U/ml), IL-10 (final concentration 10 ng/ml), TGF-β (final concentration 
1 ng/ml), IL-6 (final concentration 10 ng/ml), or rTSLP (final concentration 10 or 100 
ng/ml from R & D), for 8 h.   
 
RNA isolation and real-time PCR 
RNA was isolated from intestinal tissues of mice using a Trizol extraction and from 
BMDCs using RNEasy Spin Columns (Qiagen).  Tissues were first disrupted in a tissue 
homogenizer (TissueLyzer, Qiagen).  RNA was extracted from purified cells using 
RNeasy spin columns (Qiagen).  cDNA was synthesized from the isolated RNA using 
Superscript Reverse Transcriptase (Invitrogen).  Quantitative real-time PCR was carried 
out on cDNA samples using commercial primer sets (Qiagen) and SYBR Green 
chemistry.  All reactions were run on an ABI 7500 Fast Real-Time PCR System (Applied 
Biosystems).  Samples are normalized to naïve controls unless otherwise stated. 
   
Tissue staining 
At necropsy, cecal and proximal large intestine sections were removed and snap-frozen 
in OCT medium (Tissue Tek, Sakura Inc.).  5 µm sections were cut and stained for TSLP 
using a biotinylated monoclonal anti-TSLP antibody (eBioscience, San Diego, CA).   
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Results 
Constitutive expression of TSLP in intestinal epithelial cells 
The GI tract is composed of region-specific microenvironments defined by the presence 
of distinct accessory cell and lymphocyte populations and varied populations of 
commensal bacteria (Mowat 2003; Macdonald and Monteleone 2005; Artis 2008). The 
large intestine differs from the small intestine in immuno-regulatory pressures as it 
carries a higher level of commensal bacteria and is a common site for intestinal 
inflammatory diseases like ulcerative colitis (Tlaskalova-Hogenova, Stepankova et al. 
2004).  We sought to examine whether basal expression of TSLP differed in these 
distinct microenvironments. There was low expression of TSLP in the small intestine of 
naïve mice (Figure 5A).  TSLP mRNA expression was also detected throughout the 
large intestine, with the highest expression levels in the proximal large intestine (Figure 
5A). TSLP protein expression was examined by immunofluorescent (IF) staining of 
cryosections of cecum and large intestine.  In the cecum, TSLP was found 
predominately in mature enterocytes located at the crypt table whereas in the proximal 
large intestine, TSLP was expressed throughout the length of the crypt (Figure 5B).  The 
variable expression of TSLP throughout the length of GI tract suggests differential 
regulation depending on microenvironment.  Although the mechanisms regulating TSLP 
expression remain undefined, our results demonstrate constitutive IEC TSLP production 
in the large intestine. 
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Figure 5 TSLP is constitutively expressed in intestinal epithelial cells 
 
Figure 5. TSLP is basally expressed in the large intestine.  (A) RNA was isolated 
from sections of the intestine and expression of TSLP was analyzed by RT-PCR.  
Values represent % of actin expression in each sample.  DSI, distal small intestine, 
Ce, cecum, prox, proximal, dis, distal.  Error bars indicate s.e.m.  (B) IF staining of 
TSLP (red) in intestinal cryosections, co-stained with DAPI (blue).  Bar, 50 µm. 
Data represents two individual experiments with 2-3 mice per group. 
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TSLPR and IL-7Rα (CD127) are co-expressed on CD11c+ DCs 
While both human and murine CD11c+ DCs have been shown to be responsive to TSLP 
in vitro (Soumelis, Reche et al. 2002; Rimoldi, Chieppa et al. 2005; Zaph, Troy et al. 
2007), expression of TSLPR-α chain and CD127 on DCs directly ex vivo has not been 
extensively characterized.  Further, it is not known if signals present in the tissue 
microenvironment can influence expression of either chain of the TSLPR complex.  In 
order to fully characterize DC expression of TSLPR and CD127 within the GALT, cells 
were isolated from the spleen, mesenteric lymph node (MLN), cecal patch (CP), and the 
lamina propria of the large intestine (large intestine lamina propria lymphocytes LI LPLs) 
of naïve, WT C57/BL6 mice, stained directly ex vivo and examined by flow cytometry; 
DCs were gated as CD3-CD19- CD11c+.  The specificity of the APC-labeled anti-TSLP 
mAb was assessed and no cross reactivity was observed in splenic DCs isolated from 
TSLPR-/- mice (Figure 6A).  We found that TSLPR expression was detected on DCs 
isolated from the spleen and each compartment of the GALT examined, (Figure 6B 
upper panel).  DCs isolated from the large intestine lamina propria (LI LPL) had the 
lowest expression levels of TSLPR.  As high affinity ligand binding and signaling of TSLP 
requires pairing of the TSLPR-α chain with CD127, DC co-expression of CD127 was 
examined.  CD11c+ TSLPR+ DCs co-expressed CD127 in each tissue examined (Figure 
6B lower panel), indicating heterodimeric TSLPR expression. Intestinal DCs can be 
further separated into subsets based on expression of CD8α, CD11b, and CD103 with 
specific functions being ascribed to each phenotype (Kelsall 2008).  Analysis of TSLPR 
complex expression in CD8α+ CD11b-, CD8α- CD11b+, CD8α- CD11b-, and CD103+ DCs 
did not reveal substantial differences in between subsets in any of the GALT tissues 
analyzed (data not shown).  Additionally, TSLPR expression does not appear to be 
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linked to the activation state of DCs, as high expression of MHC class II did not correlate 
to increased expression of TSLPR in GALT DCs (data not shown).  Taken together, 
these data suggest that DCs from peripheral sites such as the spleen and from the 
GALT tissue express the functional heterodimeric TSLPR irrespective of activation 
status as measured by MHC class II expression levels.    
 
While the dynamic expression of TSLP from EC cells is known to be regulated by a 
number of external and host-derived factors (Summarized in Figure 1 and Table 1) 
(Saenz, Taylor et al. 2008), the regulation of DC TSLPR expression remains largely 
undefined.  In order to elucidate factors that could impact DC TSLPR expression, we 
utilized bone marrow-derived dendritic cells (BMDCs) as in vitro model system.  BMDCs 
were generated and found to express the TSLPR-α chain under resting conditions 
(Figure 6C).  First we assessed whether stimulation with externally derived products 
such as TLR ligands, secreted helminth products, or allergens influenced TSLPR 
expression.  Stimulation with the TLR agonists LPS and CpG resulted in little to no 
increase in TSLPR expression above steady state levels (Figure 6C). However, 
exposure of BDMCs to helminth-derived products such as Trichuris ES antigen or 
Schistosoma mansoni egg antigen (SEA) resulted in a small but consistent elevation of 
TSLPR expression (Figure 6C). These finding are consistent with increased levels of 
TSLPR mRNA found in whole intestinal tissue samples following Trichuris infection 
(Humphreys, Xu et al. 2008) or in lung tissue after exposure to Schistosoma mansoni 
eggs (Ramalingam, Pesce et al. 2009).  Treatment with the cysteine protease allergen 
papain resulted in strong upregulation of TSLPR (Figure 6C).  Next we tested whether 
cytokine signaling on the BMDCs could regulate TSLPR expression.  While stimulation 
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with IL-4, TGF-β, and IL-6 resulted in moderate upregulation of TSLPR (Figure 6D), 
treatment with IFN-γ and IL-10 resulted in strong upregulation of TSLPR in BMDCs 
(Figure 6D).  BMDCs were also treated with the TH2-associated cytokine IL-25 which 
failed to increase TSLPR expression (data not shown).  Stimulation with rTSLP resulted 
in a down-regulation of surface TSLPR expression (Figure 6E).  Further studies need to 
be done to determine if this decrease is representative of receptor endocytosis.  BMDC 
expression of CD127 was also examined following stimulation and failed to show 
dynamic regulation in surface expression (data not shown).  As BMDC expression of 
CD127 is lower than on CD11c+ DCs isolated directly ex vivo, these results were also 
confirmed using RTPCR, which showed no significant changes in CD127 mRNA levels 
following stimulation (data not shown).   
 
Additionally, in order to investigate the relationship between DC activation and TSLPR 
expression, surface expression of the co-stimulatory molecule CD86 was examined.  As 
expected, stimulation of BMDCs with LPS and IFN-γ strongly increased CD86 
expression (Figure 6C,D lower panel).  However, the increase in activation status (as 
measured by the upregulation of co-stimulatory molecules) did not directly correlate to 
increased TSLPR expression, as strong upregulation of TSLPR was seen following IFN-
γ but not LPS stimulation (Figure 6C,D).  Further supporting this, TSLPR expression was 
increased in response to IL-10 and TGF-β (Figure 6C, D), two cytokines that do not 
activate BMDCs.  These results indicate that TSLPR expression is not directly linked to 
the activation status of the DC.   
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Figure 6 GALT DCs co-express TSLPR-α chain and CD127 
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Figure 6 GALT DCs co-express TSLPR-α chain and CD127
Figure 6 CD11c+ DCs from the GALT co-express TSLPR and CD127.  (A) Splenic 
CD11c+ DCs from WT and TSLPR-/- mice expression of TSLPR assayed by flow 
cytometry.  (B) Expression  of TSLPR complex on DCs isolated from the spleen, 
mesenteric lymph node (MLN), cecal patch (CP), large intestine lamina propria (LI 
LP). Top panel, TSLPR expression, plots are gated on viable CD3- CD19- CD11c+ 
cells.  Numbers are frequencies of TSLPR+ cells.  Bottom panel, CD127 co-
expression, plots are gated on CD3- CD19- CD11c+ TSLPR+ cells.  WT, black line, 
unstained controlled, solid gray histogram. (C-E) BMDC expression of TSLPR 
following 8 hr stimulation.  Top panel TSLPR expression, plots are gated on 
CD11c+ cells. FMO control, solid gray histogram, media alone, black line, 
stimulation, dashed gray line.  Numbers equal mean fluorescent intensity.  Bottom 
panel CD86 expression, media, black line, stimulation, gray dashed line. (C) 
Externally-derived stimuli. (D) Host-derived stimuli. (E) rTSLP.  Data represents 
three individual experiments with 3-4 mice per group (A, B) or two independent 
experiments with conditions run in duplicate (D-E). 
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TSLPR complex expression on macrophages and granulocytes 
 Although the majority of studies to date have focused on the ability of TSLP to influence 
DC cell function, recent reports have highlighted that TSLP may also act upon other 
innate cell populations such as mast cells (Allakhverdi, Comeau et al. 2007).  However, 
whether other cells of the innate immune system express the TSLPR complex remains 
unknown.  To investigate this, TSLPR and CD127 surface expression was analyzed on 
macrophages (SSCAhi, F4/80+), neutrophils (Gr1+), eosinophils (SiglecF+), basophils 
(CD3- CD19- FcεR1+ CD49b+), and mast cells (CD3- CD19- FcεR1+ ckit+).  Cells were 
isolated from the blood, spleen, MLN, CP, and LI LP, and examined directly ex vivo for 
TSLPR complex surface expression.  Surface expression did not appear to vary 
between tissue types examined regardless of cell population (data not shown) however, 
due to the rarity of certain cell subsets in GALT tissues under steady state conditions; 
the most robust data was generated from the spleen (Figure 7).  While macrophages, 
neutrophils, and eosinophils expressed low levels of TSLPR, they failed to co-express 
CD127 (Figure 7A), indicating these cells are not responsive to TSLP in the steady state.  
Consistent with previous reports of mast cell sensitivity to TSLP (Allakhverdi, Comeau et 
al. 2007; Allakhverdi, Smith et al. 2007), mast cells exhibited co-expression of TSLPR 
and CD127 (Figure 7B).  While basophils have been recently identified as a cellular 
source of TSLP (Sokol, Barton et al. 2008), they have not previously been reported to be 
sensitive to TSLP stimulation.  However, examination of both splenic (Figure 7B) and 
circulating basophils in the blood (data not shown) revealed co expression of TSLPR 
and CD127.  In order to determine if TSLP could impact the homeostasis of either mast 
cell or basophil populations, rTSLP was administered i.p. for four consecutive days.  
Administration of rTSLP did not influence mast cell populations but resulted in a 
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selective increase in basophils (Figure 7C) (Perrigoue, Saenz et al. 2009).  At present it 
remains undetermined if TSLP is inducing either increased basophil production/release 
from the bone marrow or if TSLP is acting to increase basophil survival in the periphery.  
Taken together, these findings suggest that TSLP has the ability to influence innate 
immunity by impacting mast cells and basophils. 
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Figure 7 TSLPR complex expression on macrophage and granulocyte cell 
populations 
Figure 7 TSLPR complex expression on macrophage and granulocyte cell 
populations.  (A) Splenic macrophage, neutrophil, and eosinophil expression of 
TSLPR (top panel) and CD127 (bottom panel).  WT, black histogram, FMO, gray 
histogram, numbers indicate mean fluorescent intensity.  (B) Splenic mast cell and 
basophil expression of TSLPR (top panel) and CD127 (bottom panel).  WT, black 
histogram, FMO, gray histogram, numbers indicate mean fluorescent intensity (C) 
Administration of rTSLP results in an increased frequency of basophils in the 
blood.  Flow cytometry of basophil frequencies in blood of mice treated daily for 4 
d with rTSLP.  Top panel, expression of IL-4-eGFP by non-B, non-T cells from the 
peripheral blood.  Bottom panel basophil frequencies in IL-4-eGFP+, non-B, non-T 
cell populations.  Numbers adjacent to outlined areas indicate percent among total 
cells of gated population.  Data represents three independent experiments with 2-4 
mice per group. 
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CD3+ CD4+ T cells co-express TSLPR and CD127 
While TSLP maintains the ability to modulate CD4+ T cell function by influencing DC-
derived signals (Ziegler and Liu 2006; Liu 2007; Liu, Soumelis et al. 2007), TSLP can 
also directly impact CD4+ T cell function (Omori and Ziegler 2007; Rochman, Watanabe 
et al. 2007; He, Oyoshi et al. 2008; Lu, Wang et al. 2009).  However, the majority of 
these studies have been conducted in vitro, and it remains unclear whether CD4+ T cells 
express the TSLPR complex in vivo under steady state conditions.  Also, it is unknown 
whether different tissue microenvironments can impact CD4+ T cell TSLPR expression.  
To investigate this, lymphocytes were isolated from the spleen, MLN, CP, and LI LP and 
examined for TSLPR and CD127 surface co-expression by flow cytometry.  Viable, CD3+ 
CD4+ T cells isolated from the spleen, MLN, and CP showed low but detectable levels of 
TSLPR expression (Figure 8).  CD4+ T cell expression of TSLPR in the LI LP was 
extremely low, with only marginal staining detected above CD4+ T cells isolated from the 
LP of TSLPR-/- mice (Figure 8).  Similar to LI LP DCs, it is unknown whether this lack of 
expression is a result of tissue specific regulation or receptor endocytosis upon ligand 
binding.  Co-expression of the second chain of the TSLPR complex, CD127, was also 
examined on CD4+ TSLPR+ cells.  All CD4+ TSLPR+ T cells co-expressed CD127 
irrespective of the tissue they were isolated from (Figure 8 bottom panel).  As CD127 
binds with the common γ chain (CD132) to form the functional IL-7 receptor, and IL-7 is a 
critical survival signal for CD4+ T cells (Mazzucchelli and Durum 2007; Rochman, 
Spolski et al. 2009), this result is largely expected.  However, detection of the 
heterodimeric TSLPR complex on CD4+ T cells from WT naïve mice under steady state 
conditions indicates that TSLP may be able to influence CD4+ T cell function without 
other accessory signals or prior stimulation.   
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Figure 8 TSLPR and CD127 co-expression on CD3+ CD4+ T cells 
Figure 8 TSLPR and CD127 co-expression on CD3+ CD4+ T cells.  Top panel, 
TSLPR expression on CD4+ T cells isolated from the spleen, mesenteric lymph 
node (MLN), cecal patch (CP), large intestine lamina propria (LI LP).  Plots are 
gated on viable CD3+ CD4+  cells.  Numbers indicate frequencies of TSLPR+ cells.  
Solid gray histogram TSLPR-/-, black line, WT.  Bottom panel, CD127 co-
expression, plots are gated on CD3+CD4+TSLPR+ cells. Solid gray histogram, 
unstained controlled, WT, black line.  Data represent three independent 
experiments with 3-4 mice per group. 
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Recombinant TSLP induces phospho-STAT5 in CD11c+ and CD4+ T cells directly 
ex vivo 
Initial characterization of TSLP-TSLPR interactions found that binding of TSLP ligand to 
the TSLPR complex results in activation of STAT-5a and STAT5b in the murine B 
lymphoid cell line NAG8/7 and in human HepG2 cells transfected to express both chains 
of the receptor (Isaksen, Baumann et al. 1999; Levin, Koelling et al. 1999).  More recent 
work has shown that following in vitro stimulation, both human and murine CD4+ T cells 
respond to TSLP with increased levels of phospho-STAT5 being observed (Omori and 
Ziegler 2007; Rochman, Watanabe et al. 2007).  In order to investigate whether the co-
expression of TSLPR and CD127 on both CD4+ T cells and DCs isolated from the GALT 
resulted in the formation of a functional TSLPR complex, we sought to determine if these 
cells could respond directly ex vivo to TSLP and phosphorylate STAT5.   
 
To examine the functionality of DC TSLPR complex expression, spleens and MLNs were 
harvested from WT C57/B6 mice and TSLPR-/- mice and whole unfractionated cell 
cultures were rested overnight in low serum media prior to stimulation with rTSLP for 15 
or 30 minutes.  Following stimulation, cells were immediately fixed and stained for 
phospho-STAT5. Stimulation with GMCSF was utilized as a positive control for DC 
phospho-STAT5 staining (Figure 9A, B bottom panel), as it is known to signal through 
STAT5 (Martinez-Moczygemba and Huston 2003). As expected, stimulation with TSLP 
did not result in any upregulation of phospho-STAT5 in splenic or MLN DCs isolated 
from TSLPR-/- mice at any time point (Figure 9A, B top panel and data not shown).  
However, TSLP stimulation did result in a small but consistent upregulation of phospho-
STAT5 in WT DCs in both tissues examined at 15 minutes post stimulation (Figure 9A, B 
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middle panel).  Further, the same level of phosphorylation persisted at 30 minutes in 
both the spleen and MLN (data not shown), indicating sustained signaling. These results 
indicate that TSLPR expression on both splenic and MLN DCs is functional and that 
these DCs are capable of responding to TSLP without prior stimulation.   
 
We next examined whether CD4+ T cells could respond to TSLP directly ex vivo without 
any activation or additional stimuli.  Cells were isolated and rested as previously stated 
prior to TSLP stimulation.  Consistent with the DC results (Figure 9A, B) addition of 
rTSLP to spleen and MLN cell cultures from TSLPR-/- mice failed to result in the 
upregulation of phospho-STAT5 at any time point (Figure 9C, D and data not shown). 
CD4+ T cells from both the spleen and the MLN responded to rTSLP with between 15-
20% of CD4+ T cells staining positive for phospho-STAT5 (Figure 9C, D).  This level of 
phosphorylation was not sustained as a reduction in phospho-STAT5 cells was observed 
at 30 minutes following stimulation (data not shown).  However, CD4+ phospho-STAT5+ 
cells were detected at time points as late as ninety minutes post-stimulation in some 
experiments, potentially indicating sustained signaling in some cells (data not shown).  
Taken together, these data demonstrate that CD4+ T cells from naïve WT mice express 
the functional TSLPR complex and can respond to TSLP without in vitro activation or 
stimulation.   
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Figure 9 rTSLP activates phospho-STAT5 in CD4+ T cells and CD11c+ DCs 
Figure 9 rTSLP activates phospho-STAT5 in CD11c+ and CD4+ T cells isolated 
from the GALT. Whole splenocyte or MLN cultures were rested overnight prior to 
stimulation with rTSLP or GMCSF.  Cells were fixed and intracellularly stained and 
were analyzed by flow cytometry.  (A) Whole splenocyte cultures, gated on 
CD11c+ cells. (B) Whole MLN, gated on CD11c+ cells.  (C) Whole splenocyte 
cultures, gated on CD4+. (D) Whole MLN cultures, gated on CD4+.  Numbers 
represent frequency of phospho-STAT5+ cells.  Data represent one experiment 
with 3 mice per group. 
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Discussion 
Collectively, these results identify the cellular sources and targets of TSLP in the GALT 
and large intestine.  We show for the first time that TSLP is constitutively expressed 
throughout the large intestine at both the mRNA and protein level under homeostatic 
conditions.  Immunofluorescent staining indicates IECs as the dominant source of TSLP.   
Further, we demonstrate that DCs isolated from GALT tissues co-express both chains of 
the TSLPR complex and can respond to rTSLP stimulation directly ex vivo.  We confirm 
mast cell expression of the TSLPR complex and identify receptor complex expression on 
basophils.  Additionally, administration of rTSLP selectively increases the frequency of 
circulating basophils. Examination of CD4+ T cells from the GALT revealed TSLPR 
complex expression and the ability to respond to TSLP and phosphorylate STAT5 
without the presence of additional stimuli.  These results indicate the complex nature of 
TSLP-TSLPR interactions in GALT tissues, and indicate that TSLP may directly impact 
both innate and adaptive immune cell populations under steady state conditions. 
 
While the ability of TSLP to influence immune-mediated inflammation in the skin and the 
lung has been well characterized (Liu, Soumelis et al. 2007), the functional biology of 
TSLP in the intestine has only recently begun to be investigated.  TSLP expression in 
the small intestine was noted early (Sims, Williams et al. 2000), but it was not until the 
work of Rescigno and colleagues that TSLP was appreciated to participate in intestinal 
immune homeostasis (Rimoldi, Chieppa et al. 2005).  Human colonic epithelial cells 
were demonstrated to produce bioactive TSLP that could influence DC function (Rimoldi, 
Chieppa et al. 2005).  Our findings in the murine system also identify IECs as a 
dominant source of TSLP in the intestine, but additionally highlight possible differences 
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in expression between different intestinal microenvironments (Figure 5). As TSLP 
expression can be induced through exposure to TLR ligands (Rimoldi, Chieppa et al. 
2005; Allakhverdi, Comeau et al. 2007; Kato, Favoreto et al. 2007; Zeuthen, Fink et al. 
2008) and commensal bacteria have been demonstrated to influence cytokine 
production in the intestine (Ivanov, Frutos Rde et al. 2008; Zaph, Du et al. 2008), it is 
possible that alterations in the abundance or composition of communal bacterial 
populations in the distinct regions in the GI tract may influence TSLP mRNA expression 
either directly or indirectly through the cytokines they induce. As epithelial cell TSLP 
expression can be regulated by both external and host-derived stimuli, it will be 
important to determine the overriding factors that regulate intestinal TSLP expression 
both in the steady state and in the case of disease. Not withstanding this, the high levels 
of basal expression and the extensive distribution pattern of TSLP in the crypts of the 
proximal large intestine suggests a possible regulatory function for IEC-derived TSLP in 
intestinal immune homeostasis. 
 
Previously, due to the unavailability of reliable reagents to detect TSLPR surface 
expression, the ability to identify cellular targets of TSLP was greatly restricted.  In vitro 
studies relied upon the detection of phenotypic or functional changes in TSLP-treated 
purified cell populations.  In vivo studies noted alterations in mixed cell populations in the 
presence or absence of TSLP, making it difficult to ascertain direct versus secondary 
effects.  The development of the fluorochrome-conjugated specific anti-TSLPR mAb has 
allowed for the detection of TSLPR+ cells directly ex vivo without cell manipulation or 
stimulation.   
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Consistent with previous literature we found high levels of TSLPR complex expression in 
CD11c+ DCs (Park, Martin et al. 2000; Reche, Soumelis et al. 2001; Liu, Soumelis et al. 
2007) isolated from the spleen.  Importantly, we were also able to detect TSLPR 
complex expression on DCs isolated from GALT tissues (Figure 6), and verify its 
functionality (Figure 9), supporting a role for IEC-derived TSLP modulating intestinal DC 
function (Rimoldi, Chieppa et al. 2005).  However, DCs isolated from the LP, the most 
proximal GALT tissue to the IEC-derived TSLP, demonstrated reduced surface 
expression of TSLPR (Figure 6A).  Consistent with this, stimulation of BMDCs with 
rTSLP also resulted in downregulation of TSLPR (Figure 6E).  More studies need to be 
conducted to understand if the lower surface expression is a result of receptor 
endocytosis following ligand binding or the result of a regulatory mechanism following 
stimulation.  Conversely, the microenvironment and cytokine milieu of the LP is unique 
and distinct from the other tissues sampled and it is possible that other signals are acting 
to regulate LP DC TSLPR expression.   
 
Our in vitro BMDC studies examining the regulation of TSLPR-α chain expression 
indicate that receptor surface expression can be modulated by a variety of stimuli.  
Stimulation with TLR agonists LPS and CpG failed to upregulate TSLPR expression 
(Figure 6C) indicating that the TLR signaling pathway may not influence receptor 
expression.  However, as TSLP expression is more strongly upregulated by dsRNA 
stimulation and TLR3 signaling (Kato, Favoreto et al. 2007), a wider variety of TLR 
agonists should be sampled as possible stimuli to regulate TSLPR expression.  
Consistent with in vivo infection studies (Humphreys, Xu et al. 2008; Ramalingam, 
Pesce et al. 2009), Ag products derived from Trichuris and S. mansoni stimulated a 
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small but detectable up regulation of TSLPR expression in BMDCs (Figure 6C).  These 
results indicate that in situations of infection, pathogens may directly modulate TSLPR 
expression.  However, as these products remain unfractionated, the actual proteins or 
molecules responsible for the upregulation are unknown.  Stimulation with the cysteine 
protease allergen papain resulted in strong upregulation of TSLPR expression in BMDCs 
(Figure 6C).  As previous reports have shown papain to also target basophils (Sokol, 
Barton et al. 2008; Sokol, Chu et al. 2009), it is possible that papain may also influence 
basophil TSLPR expression. 
 
Our BMDC studies also demonstrate that both pro and anti-inflammatory cytokines can 
impact surface levels of TSLPR expression.  While treatment with IL-4, IL-6, and TGF-β 
all resulted in moderate upregulation of TSLPR expression, stimulation with IFN-γ and 
IL-10 resulted in the strongest increase in receptor expression (Figure 6D).  These 
results indicate that at least in BMDCs, regulation of TSLPR expression is not exclusive 
to TH1, TH2, or anti-inflammatory cytokines.  As the tested cytokines signal through a 
variety of pathways, and multiple JAKs and STATs are involved it remains difficult to 
determine the mechanism of regulation.  Nevertheless, these findings indicate another 
layer of regulation on DC TSLP-TSLPR interactions.  Taken together with our in vivo 
studies, these results highlight CD11c+ DCs as important cellular targets of TSLP within 
the GALT. 
 
TSLP is also able to impact other innate immune cells as both mast cells and basophils 
express the TSLPR complex (Figure 7).  Mast cells have previously been recognized to 
express both chains of the TSLPR complex at the mRNA level and to respond to 
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stimulation with TSLP when in the presence of accessory signals such as IL-1β and 
TNF-α (Allakhverdi, Comeau et al. 2007).  We confirm mast cell expression of the 
TSLPR complex and also show that basophils express TSLPR (Figure 7).  Further, 
administration of rTSLP resulted in a selective increase in frequencies of basophils, but 
not mast cells in the spleen and the blood (Figure 7) (Perrigoue, Saenz et al. 2009).  The 
mechanism responsible for the increased accumulation of basophils remains unclear. 
TSLP may be acting to increase basophil survival in the periphery or to increase 
basophil release from the bone marrow. While it remains unknown if TSLP is directly 
signaling on basophils or is acting through an accessory cell population, expansion of 
the basophil population indicates a potential mechanism for TSLP to influence innate 
immune responses.  As both mast cells and basophils are known to be important 
effectors in TH2 cytokine-mediated inflammation and immune responses (Galli 2000; 
Galli, Kalesnikoff et al. 2005; Min 2008; Min and Paul 2008) and TSLP is known to 
promote TH2 cytokine-mediated inflammation (Liu 2006; Liu, Soumelis et al. 2007), TSLP 
may in part be acting through the activation or recruitment of these cell populations.  
Importantly, in situations of overexpression, TSLP has been shown to promote TH2 
cytokine-mediated in the absence of T or T and B cells (Yoo, Omori et al. 2005; Li, 
Hener et al. 2006).   Collectively, these findings implicate basophils and mast cells as 
relevant in vivo cellular targets of TSLP that must taken into account when analyzing the 
impact of TSLP-TSLPR interactions on innate and adaptive immunity. 
 
TSLP has been demonstrated to act on CD4+ T cells in vitro following 
stimulation/activation (Omori and Ziegler 2007; Rochman, Watanabe et al. 2007; Lu, 
Wang et al. 2009).  Our findings suggest that CD4+ T cells isolated from the spleen and 
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GALT express both chains of the TSLPR complex under steady state conditions in vivo 
(Figure 8) and can also respond directly ex vivo to stimulation with rTSLP (Figure 9).  
These results indicate that in addition to potentially influencing activated CD4+ T effector 
cells during an immune response; TSLP may also directly act on CD4+ T cells during 
homeostatic conditions.  While the contribution of TSLP signaling on CD4+ T cells in vivo 
remains unknown, the ability of TSLP to directly influence T cell function must be 
recognized and accounted for in future experiments. 
 
Overall, these data indicate that within the intestinal immune system, IEC-derived TSLP 
maintains the ability to target and impact cellular components of both the innate and 
adaptive immune response.  Thus, the TSLP-TSLPR interactions in the GALT represent 
a complex network with many potential players. 
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CHAPTER 3: TSLP is required for immunity to Trichuris muris, however 
TSLP independent TH2 cytokine dependent immune responses can develop 
in the absence of IFN-γ  
 
Abstract 
Intestinal epithelial cells (IECs) produce thymic stromal lymphopoietin (TSLP), however 
the in vivo influence of TSLP-TSLP receptor (TSLPR) interactions on immunity and 
inflammation in the intestine remains unclear.  Here we show that TSLP-TSLPR 
interactions are critical for immunity to the intestinal pathogen Trichuris.  Monoclonal 
antibody-mediated neutralization of TSLP or deletion of the TSLPR in normally resistant 
mice resulted in defective expression of TH2 cytokines and persistent infection.  
Susceptibility was accompanied by elevated production of IFN-γ and IL-17A and the 
development of severe intestinal inflammation.  Critically, neutralization of IFN-γ in 
Trichuris-infected TSLPR-/- mice restored TH2 cytokine responses and resulted in worm 
expulsion, providing the first demonstration of TSLPR-independent pathways for TH2 
cytokine production.   
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Introduction 
Originally characterized as a B cell growth factor, TSLP is now known for its ability to 
promote TH2 cytokine responses both in vitro and in vivo.  Clinically, TSLP has been 
linked to the TH2 cytokine-mediated pathologies of atopic dermatitis and asthma.  Skin 
biopsies from atopic dermatitis lesions showed greatly enhanced levels of TSLP 
compared with non-lesion biopsies (Soumelis, Reche et al. 2002), and heightened TSLP 
expression was detected in the airways of asthmatic patients and correlated with 
disease severity (Ying, O'Connor et al. 2005). 
 
 In vitro studies demonstrated that TSLP-conditioned human DCs can promote TH2 cell 
responses (Soumelis, Reche et al. 2002; Al-Shami, Spolski et al. 2005; Ito, Wang et al. 
2005; Rimoldi, Chieppa et al. 2005).  Mechanistically, TSLP treatment of DCs induces 
TH2 cell differentiation by inhibiting IL-12 production while simultaneously inducing 
OX40L expression (Ito, Wang et al. 2005; Rimoldi, Chieppa et al. 2005; Liu 2007).  The 
in vivo functions of TSLP have been most extensively studied in the skin and the lung 
(Soumelis, Reche et al. 2002; Al-Shami, Spolski et al. 2005; Yoo, Omori et al. 2005; 
Zhou, Comeau et al. 2005). Transgenic over-expression of TSLP in cutaneous or 
pulmonary epithelial cells results in the onset of TH2 cytokine-mediated inflammation 
resembling atopic dermatitis or asthma respectively (Yoo, Omori et al. 2005; Zhou, 
Comeau et al. 2005).  Based on these studies it has been proposed that TSLP is both 
necessary and sufficient for the initiation of TH2 cytokine-driven inflammation (Liu 2006; 
Ziegler and Liu 2006; Liu, Soumelis et al. 2007).   
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While TSLP is clearly linked to the promotion of pathogenic TH2 cytokine-mediated 
immune responses in the skin and the lung, the role for TSLP in the intestine remains 
less defined.  Expression of TSLP under steady state conditions has been shown to be 
important in maintaining intestinal immune hyporesponsiveness (Rimoldi, Chieppa et al. 
2005).  Additionally, we recently showed that TSLP responsiveness is an important 
component of early immunity to the intestinal nematode pathogen Trichuris (Zaph, Troy 
et al. 2007).  However, the mechanisms and absolute requirements for TSLP-TSLPR 
interactions in the regulation of intestinal immunity and inflammation in vivo remain 
unknown.  In this chapter we characterize the role of TSLP-TSLPR interactions in 
immunity to Trichuris infection.  We demonstrate that in the absence of TSLP-TSLPR 
interactions mice become susceptible to infection and develop severe infection-induced 
inflammation accompanied by increased production of proinflammatory cytokines.  
However, in the absence of IFN-γ, TSLP is not required for resistance to Trichuris, 
indicating TSLP-independent TH2 cytokine responses in the intestine.   
 71 
Materials and Methods 
Animals 
Wild type C57BL/6J transgenic mice were obtained from Jackson Laboratories (Bar 
Harbor, ME).  TSLPR+/+ and TSLPR-/- mice were obtained from Dr. James Ihle at St. 
Jude’s Children’s Hospital, Nashville TN.  Mice were bred and maintained in a specific-
pathogen free environment at the University of Pennsylvania.  Animal protocols were 
approved by the University of Pennsylvania Institutional Animal Care and Use 
Committee (IACUC) and all experiments were carried out following the guidelines of the 
University of Pennsylvania IACUC.   
 
Parasites and antigens 
Trichuris muris was maintained in genetically susceptible animals (Wakelin 1967; 
Wakelin 1969); isolation of Trichuris excretory-secretory (ES) antigen (Ag) and eggs was 
carried out as previously described (Artis, Villarino et al. 2004).  Mice were infected on 
day 0 with 150-200 embryonated eggs and parasite burdens were assessed at various 
time points following infection. Serum was analyzed by ELISA for Trichuris-specific 
IgG2a as previously described (Artis, Shapira et al. 2002). 
 
Cytokines and monoclonal antibodies 
Neutralizing monoclonal antibody against IFN-γ (XMG-6) was purified from ascites by 
ammonium sulfate precipitation and dialyzed against PBS.  Mice were injected i.p. with 1 
mg antibody at the time of infection and every five days post-infection.  Neutralizing 
monoclonal antibody against murine TSLP (M702) was obtained from Amgen.  Mice 
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were injected i.p. with 1 mg antibody at the time of infection and every five days post-
infection. 
 
Isolation of cells and flow cytometry staining 
At necropsy, MLN were harvested and single-cell suspensions were prepared in DMEM 
supplemented with 10% heat-inactivated FBS, 2mM glutamine, 100 U/ml penicillin, 100 
µg/ml streptomycin, 25mM HEPES, and 5 x 10-5 M 2-ME.  A portion of cells was 
analyzed ex vivo for cytokine production by stimulating with 10 µg/ml brefeldin A, 50 
ng/ml PMA, and 750 ng/ml ionomycin for 4-5 h.  For DC experiments, MLN cells were 
restimulated in the presence of T. muris ES antigen (50 µg/ml) and BFA (10 µg/ml).  
Cells were then harvested and stained with fluorochrome-conjugated antibodies against 
CD4, IFN-γ, IL-13, CD11c, CD8α, CD11b, TNF-α and IL-12/23p40.  Cells were analyzed 
by flow cytometry on a FACScalibur using CellQuest Pro software (BD Pharmingen); 
further analysis was then carried out using FlowJo software (Treestar, Inc.).  MLN cells 
were restimulated by plating cells in medium alone, in the presence of T. muris ES Ag 
(50 µg/ml), or with 1 µg/ml each of soluble α-CD3 and α-CD28 antibodies.  Following 72 
h in culture, cells were stimulated with PMA and ionomycin in the presence of brefeldin A 
for 4-5 h.  Cell-free supernatants were then harvested and analyzed for cytokine 
secretion by sandwich ELISA (eBioscience, San Diego, CA).  The cells were then 
harvested and analyzed for cytokine production as described for the ex vivo analysis. 
 
Tissue staining and RELMβ responses 
At necropsy, cecal sections were removed and fixed in 4% paraformaldehyde or snap-
frozen in OCT medium (Tissue Tek, Sakura Inc.).  5 µm paraffin-embedded sections 
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were cut and stained with H&E, PAS/Alcian Blue, or by IF for RELMβ and GOB5 for 
visualization of goblet cell responses.  IF staining was carried out as previously 
described (Zaph, Troy et al. 2007). Fecal protein isolation was performed as previously 
described (Artis, Wang et al. 2004).  Samples were equalized by protein content and 
analyzed by SDS-PAGE and then immunoblotted for RELMβ using a polyclonal rabbit α-
murine RELMβ antibody (Peprotech, Rocky Hill, NJ). 
 
RNA isolation and real-time PCR 
RNA was isolated from intestinal tissues of mice using a Trizol extraction and from 
BMDCs using RNEasy Spin Columns (Qiagen).  Tissues were first disrupted in a tissue 
homogenizer (TissueLyzer, Qiagen).  cDNA was synthesized from the isolated RNA 
using Superscript Reverse Transcriptase (Invitrogen).  Quantitative real-time PCR was 
carried out on cDNA samples using commercial primer sets (Qiagen) and SYBR Green 
chemistry.  All reactions were run on an ABI 7500 Fast Real-Time PCR System (Applied 
Biosystems).  Samples are normalized to naïve controls unless otherwise stated. 
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Results 
In vivo neutralization of TSLP in WT mice results in susceptibility to Trichuris 
Challenge of genetically resistant mice with the intestinal nematode pathogen Trichuris 
results in the dynamic upregulation of TSLP mRNA in the large intestine early during 
infection (Humphreys, Xu et al. 2008).  Further, we recently demonstrated that in the 
absence of the TSLP receptor, genetically resistant mice show an early defect in the 
clearance of Trichuris (Zaph, Troy et al. 2007).  However, TSLP has been shown to 
influence lymphocyte development both in vivo and in vitro (Levin, Koelling et al. 1999; 
Sims, Williams et al. 2000; Chappaz, Flueck et al. 2007) and previous work has 
established that alterations in the circulating levels of TSLP can influence the frequency 
and composition of B cell populations in vivo (Astrakhan, Omori et al. 2007).  To 
investigate whether the impaired early immunity to infection in the TSLPR-/- mice was 
due to alterations in immune cell development or a definitive requirement for TSLP in 
protective immunity, we neutralized endogenous TSLP in genetically resistant animals 
during Trichuris infection using a neutralizing anti-TSLP monoclonal antibody (mAb).   
While mesenteric lymph node (MLN) cells isolated from control treated WT mice at day 
21 post-infection produced IL-4 and IL-13 following antigen-specific restimulation, MLN 
cells isolated from anti-TSLP mAb-treated mice exhibited significantly reduced 
expression of these cytokines (Figure 10A).  Consistent with a defect in TH2 cell 
differentiation in vivo, the frequency of IL-13+ CD4+ T cells was lower in MLN isolated 
from anti-TSLP mAb-treated than in control-treated mice (Figure 10B).  Expression of 
TH2 cytokines in the intestine leads to physiological changes in the intestinal epithelium 
including increased cell turnover, goblet cell hyperplasia, and the elevated expression of 
goblet cell-associated genes that are correlated with worm expulsion (Theodoropoulos, 
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Hicks et al. 2001; Artis, Wang et al. 2004; Artis 2006; Nair, Guild et al. 2006; Wilson, 
Zaph et al. 2006; Zaph, Rook et al. 2006; Anthony, Rutitzky et al. 2007).  Histological 
examination of ceca isolated from infected WT animals revealed goblet cell hyperplasia 
and increased mucin staining, consistent with the presence of TH2 cytokines (Figure 
10C).  In contrast, mucin staining of cecal tissue sections from anti-TSLP mAb-treated 
mice failed to show detectable goblet cell responses (Figure 10C).  Expression of the 
goblet cell-specific proteins RELMβ and GOB5 were also decreased in the anti-TSLP 
mAb treated mice (Figure 10D).  Further, RELMβ secretion, as determined by protein 
analysis of fecal samples, was also defective in infected mice treated with anti-TSLP 
mAb (Figure 10E).  Consistent with these defective TH2 cytokine responses, anti-TSLP 
mAb treated mice failed to exhibit worm expulsion at day 21 post-infection (Figure 10F).  
These results show that optimal expression of TSLP is critical for the development of 
pathogen-specific TH2 cytokine responses and early immunity to Trichuris. 
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Figure 10 In vivo neutralization of TSLP in WT mice results in susceptibility to 
Trichuris muris 
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Figure 10 In vivo neutralization of TSLP in WT mice results in susceptibility to 
Trichuris muris
Figure 10. In vivo neutralization of TSLP in WT mice results in susceptibility to 
Trichuris. (A) Antigen-specific cytokine production from restimulated MLN cells 
was determined by ELISA. (B) Frequencies of CD4+ IL-13+ T cells in the MLN 
following 72h Ag restimulation.  Plots are gated on CD4+ T cells.  (C - E) Anti-
TSLP treated mice fail to induce goblet cell responses following infection.  (C) 
Paraffin sections of cecal tissue were stained with PAS/Alcian blue for goblet cell 
visualization. (D) Paraffin sections of cecal tissue were IF stained for RELMβ and 
GOB5 (green) and co-stained with DAPI (blue).  (E) Protein isolated from fecal 
pellets on various days post infection was analyzed by SDS-PAGE and 
immunoblotted for RELMβ, N – naïve, uninfected control. (F) Worm burdens were 
assessed at day 21 post-infection. Bar, 50 µm. Error bars indicate s.e.m. Data 
represents three individual experiments with 3-6 mice per group.   
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TSLP-TSLPR interactions are critical for immunity to Trichuris 
Deletion of TSLPR in normally resistant mice resulted in increased IFN-γ production and 
elevated worm burdens at day 21 post-infection (Zaph, Troy et al. 2007).   In genetically 
resistant strains of mice, CD4+ TH2 cell-mediated expulsion of Trichuris occurs between 
days 18-21 while genetically susceptible mice develop persistent infection and retain 
parasites for the lifetime of the host (Else, Finkelman et al. 1994).  However, impaired 
early worm expulsion is not always indicative of a failed host-protective response.  For 
example, Trichuris-infected mice deficient in ICOS fail to expel worms at day 18 post-
infection but are able to successfully mount a protective TH2 cytokine-mediated response 
and clear infection by day 34 post-infection (Wilson, Zaph et al. 2006).  Thus TSLP-
TSLPR interactions could be required for optimal early TH2 cytokine responses but not 
for subsequent TH2 cell-mediated clearance of infection.   
 
To determine whether blockade of the TSLP-TSLPR pathway resulted in persistent 
chronic infection or simply resulted in delayed worm expulsion, TSLPR+/+ and TSLPR-/- 
mice were infected with Trichuris and the kinetics of worm expulsion were monitored 
over 34 days.  MLN cells isolated from infected TSLPR-/- mice failed to produce 
detectable levels of TH2 cytokines (Figure 11A).  Histological examination of cecal 
sections also revealed defective TH2 cytokine-dependent goblet cell hyperplasia in 
infected TSLPR-/- mice in comparison to infected TSLPR+/+ mice (Figure 11B).  Further, 
production of goblet cell-derived RELMβ and GOB5 was decreased in infected TSLPR-/- 
mice compared to infected TSLPR+/+ mice (Figure 11C).  Luminal secretion of RELMβ 
was also decreased and unsustained in infected TSLPR-/- mice (Figure 11D).  The 
defective TH2 cytokine responses functionally altered the outcome of infection, as 
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TSLPR-/- mice failed to mediate worm expulsion even at a late time points and remained 
heavily infected at day 34 post-infection (Figure 11E).  In addition, chronic infection was 
also observed in WT mice treated with anti-TSLP mAb as they exhibited high worm 
burdens at day 34 post-infection (Figure 12).  Taken together, neutralization of TSLP 
and deletion of the TSLPR identify a critical role for TSLP-TSLPR interactions in the 
development of a host protective TH2 cytokine-dependent immune response to Trichuris.  
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Figure 11 TSLP-TSLPR interactions are critical for immunity to Trichuris muris 
Figure 11. TSLP responsiveness is required for immunity to Trichuris muris. (A) 
TSLPR-/- mice are unable to induce TH2 cytokine production.  Antigen-specific 
cytokine production from restimulated MLN cells was determined by ELISA. (B - D) 
TSLPR-/- mice have decreased goblet cell responses. (B) Cecal sections from 
TSLPR+/+ or TSLPR-/- mice were taken at day 20 post-infection and stained 
PAS/Alcian blue.  (C) Paraffin sections of cecal tissue were IF stained for RELMβ 
and GOB5 (green) and co-stained with DAPI (blue). (D) Protein isolated from fecal 
pellets on various days post infection was analyzed by SDS-PAGE and 
immunoblotted for RELMβ.  (E) Worm burdens in TSLPR+/+ and TSLPR-/- mice 
were assessed at days 20 and 34 post-infection. Bar, 50 µm.  Error bars indicate 
s.e.m. Data represents three individual experiments with 3-4 mice per group. 
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Figure 12 Anti-TSLP treatment in WT mice results in chronic infection 
Figure 12.  In vivo depletion of TSLP in WT mice results in chronic Trichuris 
infection. Worm burdens were assessed at day 34 post-infection.  Error bars 
indicate s.e.m.  Results are representative of two individual experiments with 3-4 
mice per group. 
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Increased infection-induced inflammation and proinflammatory cytokine 
production in the absence of TSLP-TSLPR interactions 
The defective production of TH2 cytokines and susceptibility to Trichuris following the 
disruption of the TSLP-TSLPR pathway could be the result of impaired responsiveness 
to infection or dysregulation of T helper cell responses.  Histological examination of 
cecal sections taken at day 34 post-infection revealed immune-mediated alterations in 
both WT and TSLPR-/- mice (Figure 13A).  Cecal sections from WT mice exhibited 
minimal to mild submucosal edema, mixed inflammatory cell infiltrate and mild crypt 
hyperplasia indicative of a recent infection.  In contrast, TSLPR-/- mice exhibited severe 
infection-induced inflammation characterized by severe submucosal edema and 
transmural inflammation with lymphocytic infiltrate in the muscularis and mixed 
lymphocytic and neutrophilic infiltrate in the submucosa and lamina propria (Figure 13A).  
Additionally, IECs in the TSLPR-/- mice appeared activated, and numerous mitotic figures 
were observed (Figure 13B, arrows).  TSLPR-/- mice also exhibited foci of inflammation 
with disruption of crypt architecture (Figure 13C).  Depletion of TSLP in WT mice also 
resulted in severe-infection induced inflammation.  Histological examination of day 34 
post-infection cecal sections showed severe submucosal edema and transmural 
inflammation in the anti-TSLP treated mice, but not the WT mice (Figure 14 A, B).  
Further, anti-TSLP mice exhibited foci of inflammation (Figure 14 C, left panel) and 
immune cell infiltration in between the crypts (Figure 14 C, right panel), both of which 
were absent in WT mice (Figure 14 B).  The severe infection-induced inflammation 
exhibited in the absence of TSLP-TSLPR interactions contrasts with the mild to 
moderate inflammation seen in genetically susceptible AKR mice that also exhibit 
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chronic infection (Artis, Humphreys et al. 1999; Bancroft, Artis et al. 2000; Owyang, 
Zaph et al. 2006).   
 
The presence of severe intestinal inflammation in the TSLPR-/- mice suggested that 
susceptibility to Trichuris was not solely due to a lack of TH2 responsiveness, but 
involved a more general dysregulation of infection-induced innate and adaptive immune 
responses.  Consistent with this hypothesis, there was a significant increase in the 
frequency of CD4+ IFN-γ+ T cells isolated from the MLN of TSLPR-/- mice at day 21 post-
infection compared to WT mice (Figure 13D).  Restimulated MLN cells isolated from 
infected TSLPR-/- mice exhibited significantly elevated production of IFN-γ and IL-17A in 
comparison to infected WT mice following either antigen-specific or polyclonal 
stimulation (Figure 13E, F).  As anti-TSLP treated WT mice also developed severe 
infection-induced inflammation, we investigated proinflammatory cytokine production in 
these mice.  Similar to the findings with the TSLPR-/- mice, increased frequencies of 
CD4+ IFN-γ+ T cells were detected in MLNs isolated from anti-TSLP treated WT mice 
compared to WT control mice at day 21 post-infection (Figure 15A).  MLN cells from anti-
TSLP treated mice also produced significantly increased levels of IFN-γ compared to WT 
mice following Ag-specific restimulation (Figure 15B). Consistent with the upregulation of 
IFN-γ protein, anti-TSLP treated mice also exhibited increased levels of IFN-γ mRNA in 
the MLN compared to controls (Figure 15C).  Also, isolation of RNA from large intestine 
tissue samples revealed a trend towards increased levels of IL-17A mRNA in the anti-
TSLP treated mice compared to WT mice (Figure 15D).  Dysregulated proinflammatory 
cytokine expression persisted in chronic infection, as infected TSLPR-/- mice showed 
increased frequencies of CD4+ IFN-γ+ T cells in MLN compared to WT mice at day 34 
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post-infection (Figure 16).  The heightened expression of IFN-γ and IL-17A and severe 
intestinal inflammation exhibited upon disruption of the TSLP-TSLPR pathway 
demonstrates that susceptibility to infection is not solely due the impairment of TH2 
cytokine responses but also due to the development of an unregulated proinflammatory 
cytokine response. 
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Figure 13 TSLPR-/- mice have increased infection-induced inflammation and 
proinflammatory cytokine production 
Figure 13. TSLP-TSLR interactions limit proinflammatory cytokine production and 
infection-induced inflammation. (A-C)  TSLPR-/- mice have increased infection-
induced inflammation.   Paraffin-embedded cecal sections from day 34 post-
infection were stained with H&E. (B) Epithelial cells in TSLPR-/- mice exhibit 
numerous mitotic figures (arrowheads). (C) TSLPR-/- mice exhibit foci of 
inflammation with loss of crypt architecture. (D-G) TSLPR-/- mice have increased 
proinflammatory cytokine production at day 20 post-infection.  (D) Frequencies of 
CD4+ IFN-γ+ T cells in the MLN at day 20 post-infection.  (E) Antigen-specific IFN-γ 
production from restimulated MLN was determined by ELISA.  (F) Polyclonal IL-
17A production from restimulated MLN was determined by ELISA.  Error bars 
indicate s.e.m.  Data represent two to three individual experiments with 3-4 mice 
per group. 
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Figure 14 Anti-TSLP treatment in WT mice results in increased infection-induced 
inflammation 
Figure 14. Depletion of TSLP in Trichuris infected WT mice results in infection-
induced inflammation.  Paraffin-embedded cecal sections from day 34 post-
infection were stained with H&E. (A). Anti-TSLP mAb-treated mice displayed 
severe submucosal edema with mixed inflammatory cell infiltrate.  Second panel 
represents a greater magnification of boxed areas in first panel.  (B)  Increased 
magnification of a representative cecal section from WT mice showing minimal 
submucosal edema.  (C ) Increased magnification of representative cecal cross 
sections of anti-TSLP treated mice.  Sections show foci of inflammation (left panel) 
and lymphocytic infiltration between crypts (right).  Bar, 50 µm. Results are 
representative of two individual experiments with 3-4 mice per group. 
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Figure 15 Anti-TSLP treatment in WT mice results in increased proinflammatory 
cytokine production 
Figure 15. Depletion of TSLP in Trichuris infected WT mice results in increased 
expression of IFN-γ and IL-17.   (A) Anti-TSLP mAb treated mice have increased 
frequencies of CD4+ IFN-γ+ T cells in the MLN at day 21 post-infection.  Plots are 
gated on CD4+ cells.  (B) Antigen-specific IFN-γ from restimulated MLN cells by 
ELISA. (C) Anti-TSLP mAb treated mice have increased mRNA transcripts for IFN-
γ in the MLN at day 21-post infection. (D) Anti-TSLP mAb treated mice have 
increased mRNA transcript for IL-17A in the large intestine at day 34 post-
infection. Error bars indicate s.e.m.  Results are representative of three individual 
experiments with 3-6 mice per group. 
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Figure 16 TSLPR-/- mice exhibit elevated frequencies of CD4+ IFN-γ+ T cells in the 
MLN at day 34 post-infection 
 
 
 
Figure 16.  Infected TSLPR-/- mice have increased frequencies of CD4+ IFN-γ+ T 
cells in the MLN at day 34 post-infection. Plots are gated on CD4+ cells.  Results 
are representative of three individual experiments with 3-4 mice per group. 
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TSLP is not required to initiate TH2 cytokine responses in the intestine 
Previous studies in both skin and lung models of TH2 cytokine-mediated allergic 
inflammation indicated that TSLP is both necessary and sufficient to drive the 
development of TH2 cytokine-dependent inflammation, suggesting that TSLP may be a 
‘master switch’ for the development of TH2 cytokine responses (Yoo, Omori et al. 2005; 
Zhou, Comeau et al. 2005; Liu 2006).  The impaired immunity to Trichuris exhibited 
following disruption of the TSLP-TSLPR pathway supports this model.  However, anti-
TSLP mAb treatment or deletion of TSLPR resulted in heightened CD4+ T cell-derived 
IFN-γ production.  To test whether TSLP-TSLPR interactions were absolutely required or 
dispensable for Trichuris-induced TH2 cytokine responses, Trichuris-infected TSLPR-/- 
mice were treated with neutralizing monoclonal antibodies against IFN-γ throughout the 
course of infection.  If TSLP-TSLPR interactions were necessary for TH2 cytokine 
responses, anti-IFN-γ treated TSLPR-/- mice would remain susceptible to Trichuris.   
 
Following neutralization of IFN-γ in infected TSLPR-/- mice there was a marked reduction 
in the frequency of IFN-γ+ CD4+ T cells in the MLN at day 21 post-infection compared to 
control treated TSLPR-/- mice, consistent with the role of IFN-γ in promoting TH1 
responses (Figure 17A).  Coincident with decreased levels of IFN-γ there was an 
increase in levels of IL-4, IL-5, and IL-13 secreted from antigen-restimulated MLN cells 
from anti-IFN-γ treated TSLPR-/- mice compared to the control treated TSLPR-/- mice 
(Figure 17B).  Critically, the levels of IL-4, IL-5, and IL-13 in the anti-IFN-γ treated 
TSLPR-/- mice were comparable to those seen in resistant TSLPR+/+ mice (Figure 17B).  
Blockade of IFN-γ did not impact Trichuris-specific IgG1 serum antibody levels (data not 
shown), but did inhibit the development of a Trichuris-specific IgG2a serum antibody 
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response, as serum levels of IgG2a in anti-IFN-γ treated TSLPR-/- mice were comparable 
to levels in TSLPR+/+ mice (Figure 17C). Goblet cell responses were restored as the 
expression of both GOB5 and RELMβ were increased in anti-IFN-γ treated TSLPR-/- 
mice (Figure 17D,E).  Further, histological examination revealed that the severe crypt 
elongation, edema and inflammatory infiltrate present in the Trichuris-infected TSLPR-/- 
mice were absent following anti-IFN-γ treatment (Figure 17F). Critically, anti-IFN-γ 
treatment also recovered immunity in the TSLPR-/- mice.  While control treated TSLPR-/- 
mice exhibited persistent infection, anti-IFN-γ treated mice exhibited reduced worm 
burdens at day 21 post-infection with subsequent worm expulsion and clearance by day 
34 post-infection (Figure 17G).  The delay in worm clearance from day 21 to day 34 
post-infection in the anti-IFN-γ treated TSLPR-/- mice indicates that while TSLP-TSLPR 
interactions are not required for immunity, they may play an important role in the 
development of optimal protective immune responses following Trichuris infection.  Anti-
IFN-γ treatment also augmented levels of total serum IgE (Figure 18).  These results 
demonstrate that in the absence of IFN-γ in an in vivo system, TSLP-independent 
mechanisms allow for the generation of a protective TH2 cytokine response in the 
intestine. 
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Figure 17 Neutralization of IFN-γ in susceptible TSLPR-/- mice restores TH2 
cytokine production and immunity 
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Figure 17 Neutralization of IFN-γ in susceptible TSLPR-/- mice resotres TH2 
cytokine production and immunity
Figure 17. TSLP is not required for the initiation of an intestinal TH2 cytokine 
response to Trichuris. (A) Frequencies of CD4+ IFN-γ+ T cells isolated from the 
MLN and stimulated directly ex vivo.  (B) Antigen-specific cytokine production from 
restimulated MLN cells was determined by ELISA. (C) Antigen-specific serum 
IgG2a levels. (D, E) Antibody treatment restored goblet cell function in TSLPR-/- 
mice. (D) Protein isolated from fecal pellets on various days post infection was 
analyzed by SDS-PAGE and immunoblotted for RELMβ.  (E) Paraffin sections of 
cecal tissue were IF stained for RELMβ and GOB5 (green) and co-stained with 
DAPI (blue). (F) Day 34 cecal sections were stained with H&E. (G) Worm burdens 
were assessed at days 21 and 34 post-infection.  Bars, 50 µm. Error bars indicate 
s.e.m.  Data are representative of two individual experiments with 3-4 mice per 
group. 
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Figure 18 Anti-IFN-γ treatment increases serum IgE levels 
 
 
Figure 18.  Anti-IFN-γ treatment of Trichuris-infected TSLPR-/- mice increases total 
serum IgE levels at day 21 post-infection. Error bars indicate s.e.m.  Data is 
representative of two individual experiments with 3-4 mice per group.  
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Discussion 
These findings indicate a key role for TSLP-TSLPR interactions in regulating intestinal 
immunity and inflammation.  We show for the first time that the TSLP-TSLPR pathway 
within the intestine is critical for host-protective immunity, as disruption of TSLP-TSLPR 
interactions in vivo led to susceptibility to Trichuris infection.  Following infection, anti-
TSLP mAb-treated WT mice and TSLPR-/- mice remained chronically infected, had 
elevated expression of IFN-γ and IL-17A, and exhibited severe infection-induced 
inflammation. However, unlike models of inflammation in the skin or the lung, we found 
that TSLP was not critically required for pathogen-specific TH2 cytokine responses in the 
intestine.  Infected TSLPR-/- mice treated with neutralizing anti-IFN-γ antibodies 
recovered pathogen-specific TH2 cytokine production and immunity, thus identifying 
TSLP-independent pathways for the initiation of intestinal TH2 cytokine responses. 
 
The putative link between TSLP and the promotion of TH2 cytokine responses has been 
well developed in both in vitro and in vivo studies (Liu 2006; Ziegler and Liu 2006; Liu, 
Soumelis et al. 2007).  Initial in vitro studies found that human monocyte-derived DCs 
treated with TSLP induced CD4+ T cells to produce IL-4 upon co-culture (Soumelis, 
Reche et al. 2002; Al-Shami, Spolski et al. 2005; Rimoldi, Chieppa et al. 2005), and that 
TSLP-induced upregulation of OX40L on DCs promoted CD4+ TH2 cell differentiation 
(Ito, Wang et al. 2005).  Recent work also demonstrated the ability of TSLP to directly 
influence both human and murine CD4+ T cells (Omori and Ziegler 2007; Rochman, 
Spolski et al. 2009).  In the murine system, in vitro treatment of purified CD4+ T cells with 
TSLP induced T cell IL-4 production and TH2 cell (Omori and Ziegler 2007).  Further, in 
the presence of TNF-α or IL-1, TSLP has been shown to induce production of the TH2 
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cytokines IL-5 and IL-13 from mast cells (Allakhverdi, Comeau et al. 2007).  Supporting 
these in vitro studies, the transgenic over-expression of TSLP by epithelial cells in the 
skin or the lung induces TH2 cytokine-mediated inflammation in vivo (Yoo, Omori et al. 
2005; Zhou, Comeau et al. 2005).  Thus, through its ability to influence both innate cell 
populations as well as CD4+ T cells, TSLP could contribute both directly and indirectly to 
TH2 cell differentiation in vivo.   
 
TSLP may act to directly influence TH2 cell differentiation by directly influencing CD4+ T 
cell cytokine production.  For example, TSLP has been shown to promote il-4 gene 
transcription in CD4+ T cells (Omori and Ziegler 2007).  While the exact mechanisms 
remain unknown, it is possible that TSLP-induced STAT5 activation plays a role in 
promoting Il-4 gene transcription independently of IL-4, STAT6, or GATA-3 (Zhu, Cote-
Sierra et al. 2003; Takatori, Nakajima et al. 2005; Zhu, Yamane et al. 2006).  Once 
transcription is initiated, IL-4 may act in an autocrine fashion on CD4+ T cell to activate 
STAT6 and upregulate GATA-3 expression, promoting and stabilizing TH2 cell 
differentiation (Murphy and Reiner 2002; Mowen and Glimcher 2004). 
 
Indirectly, TSLP could promote TH2 cell differentiation by influencing innate cell 
responses.  TSLP may induce mast cell production of IL-13, which could signal through 
STAT6 to promote proximal events including GATA-3 upregulation in TH2 cell 
differentiation (Murphy and Reiner 2002; Mowen and Glimcher 2004).  Additionally, 
administration of rTSLP elicits increased frequencies of basophils (Chapter 2 and 
(Perrigoue, Saenz et al. 2009)), and basophils have recently been demonstrated to be 
important antigen presenting cells in the initiation of TH2 cytokine immune responses 
 96 
(Perrigoue, Saenz et al. 2009; Sokol, Chu et al. 2009; Yoshimoto, Yasuda et al. 2009). 
Neither of these possibilities is mutually exclusive however, and it is likely that TSLP acts 
through multiple pathways to promote TH2 cell differentiation and TH2 cytokine 
production.  
 
Beyond an influence on TH2 cytokine production, TSLP may also regulate recruitment 
and/or retention of immune cells at the site of infection or inflammation.  For example, 
TSLP treatment of human mDCs induces expression of the chemokines CCL17 and 
CCL22, known ligands for CCR4, a chemokine receptor found on effector TH2 cells 
(Soumelis, Reche et al. 2002; Liu 2006).  Thus following exposure to Trichuris, IEC-
derived TSLP could be acting on intestinal DCs to simultaneously create conditions 
permissive to TH2 cell differentiation and to promote TH2 effector cell recruitment or 
retention in the intestine. 
 
While these data support a role for TSLP in directly influencing and promoting TH2 
cytokine responses, our finding that TSLP was not critically required for the initiation of a 
pathogen-specific TH2 cytokine response following Trichuris infection demonstrates that 
there are TSLP-independent pathways for the generation of intestinal TH2 cytokine 
responses.  In the absence of TSLP it is possible that a combination of other TH2-
promoting factors present in the intestine is able to compensate and either act alone or 
in concert to create a microenvironment permissive for TH2 cell differentiation. 
Candidates include cytokines such as IL-25 and IL-33 as they have each been 
demonstrated to promote TH2 cytokine responses (Fort, Cheung et al. 2001; Schmitz, 
Owyang et al. 2005).  Further, both IL-25 and IL-33 have been shown to play important 
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roles in immunity to Trichuris infection (Owyang, Zaph et al. 2006; Humphreys, Xu et al. 
2008; Saenz 2008).  The Notch-Notch ligand pathway may also play a role in the 
generation of TSLP-independent TH2 cytokine responses in the intestine.  Previous work 
has demonstrated that Notch-Notch ligand interactions are important in mediating 
immunity to Trichuris (Tu, Fang et al. 2005), and Notch may act either directly in the 
promotion of TH2 cell differentiation (Ansel, Djuretic et al. 2006; Amsen, Antov et al. 
2007; Fang, Yashiro-Ohtani et al. 2007; Kubo 2007; Perrigoue, Marshall et al. 2008) or 
through its influence on epithelial cell function (Demehri, Liu et al. 2008).  Thus, TSLP 
may be another factor that, while not itself essential for the development of TH2 cytokine 
responses in the intestine, is critical in combination with a number of other factors to 
create a TH2 permissive microenvironment.  Additionally, as anti-IFN-γ treated TSLPR-/- 
mice displayed delayed worm clearance during Trichuris infection, TSLP-TSLPR 
interactions may also be important in determining the magnitude and/or kinetics of TH2 
cytokine responses in the intestine.  As TSLP does not appear to be strictly required for 
intestinal TH2 cytokine responses, and loss of TSLP-TSLPR interactions resulted in 
increased infection-induced proinflammatory cytokine production and inflammation, it is 
possible that TSLP may also have another regulatory role in the intestine.  The 
hypothesis that TSLP is important in the regulation of intestinal proinflammatory cytokine 
production will be tested in Chapter 4.   
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CHAPTER 4: A role for TSLP-TSLPR interactions in the inhibition of 
proinflammatory cytokine production in the intestine 
 
Abstract 
The importance of TSLP-TSLPR interactions in the promotion of TH2 cytokine-mediated 
inflammation has been well documented and studied. However, we previously 
demonstrated that TSLP is not critically required for intestinal TH2 cytokine responses, 
and that in the absence of TSLP-TSLPR interactions mice infected with Trichuris exhibit 
elevated proinflammatory cytokine production and increased infection-induced 
inflammation in the large intestine.  Despite these findings, little is known about the 
potential of TSLP-TSLPR interactions to regulate intestinal proinflammatory cytokine 
production.  Here, we demonstrate that naïve TSLPR-/- mice have a trend towards 
increased frequencies of CD4+ IFN-γ+ T cells in the GALT and intestine compared to 
naïve littermate control TSLPR+/+ mice.  Introduction of rTSLP into whole splenocyte 
cultures was also sufficient to inhibit IFN-γ production from CD4+ T cells in the absence 
of IL-4, indicating an IL-4-independent pathway of TSLP-dependent inhibition of IFN-γ 
production by CD4+ T cells.  TSLP was found to inhibit DC-derived IL-12/23p40 
production both in vitro and in vivo.  Additionally, TSLPR-/- mice were found to be more 
susceptible to DSS-induced colitis, exhibiting increased proinflammatory cytokine 
production and more severe intestinal inflammation compared to DSS-treated WT mice.  
Collectively, these findings suggest that TSLP-TSLPR interactions in the GALT play a 
previously unrecognized role in the regulation of proinflammatory cytokine production 
and inflammation in the intestine.   
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Introduction 
TSLP-TSLPR interactions maintain the ability to promote TH2 cytokine-mediated immune 
responses through a variety of mechanisms.  TSLP can influence DC (Soumelis, Reche 
et al. 2002; Ito, Wang et al. 2005; Rimoldi, Chieppa et al. 2005; Zaph, Troy et al. 2007), 
CD4+ T cell (Omori and Ziegler 2007; Rochman, Watanabe et al. 2007), and mast cell 
function (Allakhverdi, Comeau et al. 2007) to promote TH2 cytokine production.  As a 
result of these diverse abilities, TSLP has been recognized as a critical factor in the 
promotion of TH2 cytokine-mediated inflammation in the skin and the lung (Soumelis, 
Reche et al. 2002; Al-Shami, Spolski et al. 2005; Yoo, Omori et al. 2005; Zhou, Comeau 
et al. 2005; Liu 2006; Liu, Soumelis et al. 2007).  Further, TSLP-TSLPR interactions are 
important in the development of a host-protective TH2 cytokine response to infection with 
intestinal pathogen Trichuris muris (Chapter 3, (Zaph, Troy et al. 2007).    
 
In addition to these functions, there is also evidence to suggest that TSLP may play an 
immunoregulatory role in the inhibition of proinflammatory cytokine production within the 
intestine.  The ability of TSLP to modulate DC production of the TH1 cytokine-promoting 
factor IL-12 has been previously documented (Soumelis, Reche et al. 2002; Ito, Wang et 
al. 2005; Rimoldi, Chieppa et al. 2005; Zaph, Troy et al. 2007).  Within the intestine, 
constitutive IEC production of TSLP was found to be important in the maintenance of 
intestinal immune hyporesponsiveness through the promotion of TH2 cell differentiation 
and the inhibition of IFN-γ production (Rimoldi, Chieppa et al. 2005). Further, disruption 
of the TSLP-TSLPR pathway in mice results in increased infection-induced inflammation 
and elevated levels of IFN-γ and IL-17A following infection with Trichuris (Chapter 3 
(Zaph, Troy et al. 2007)). 
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Additionally, while TSLP-TSLPR interactions were critical for the development of a host-
protective TH2 cytokine-mediated immune response to infection with the intestinal 
parasite Trichuris, TSLP-independent TH2 cytokine immune responses developed in the 
absence of IFN-γ (Chapter 3 (Taylor, Zaph et al. 2009)).  TSLP was also not required for 
TH2 cytokine-mediated immunity to Heligomosomoides polygyrus and Nippostrongylus 
brasiliensis (Massacand, Stettler et al. 2009).  These data indicate that TSLP is not 
critically required for the development of intestinal host-protective TH2 cytokine 
responses.  Taken together with the findings of dysregulated proinflammatory cytokine 
production in the absence of TSLP, these data suggest that TSLP may also have a 
regulatatory function within the intestine.   
 
In this chapter, we demonstrate dysregulated production of GALT DC-derived IL-
12/23p40 and CD4+ T cell-derived IFN-γ in naïve TSLPR-/- mice.  While this disruption of 
intestinal immune homeostasis was not sufficient to result in the development of 
spontaneous colitis, TSLPR-/- mice do exhibit increased susceptibility to DSS-induced 
colitis.  Further, we demonstrate that IEC-derived TSLP regulates DC production of IL-
12/23p40 both in vitro and in vivo, and that addition of rTSLP into whole splenocyte 
cultures is able to inhibit CD4+ T cell production of IFN-γ in the absence of IL-4.  As a 
whole, these data indicate that in addition to its ability to promote TH2 cytokine 
responses, TSLP also acts to limit proinflammatory cytokine production and 
inflammation in the intestine.   
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Materials and Methods 
Animals 
Wild type C57BL/6J transgenic mice were obtained from Jackson Laboratories (Bar 
Harbor, ME).  TSLPR+/+ and TSLPR-/- mice were obtained from Dr. James Ihle at St. 
Jude’s Children’s Hospital, Nashville TN.  Mice were bred and maintained in a specific-
pathogen free environment at the University of Pennsylvania.  Animal protocols were 
approved by the University of Pennsylvania Institutional Animal Care and Use 
Committee (IACUC) and all experiments were carried out following the guidelines of the 
University of Pennsylvania IACUC.   
 
DSS-induced intestinal inflammation.   
DSS (MP Biomedicals) was added to drinking water at 5% weight/volume for four days.  
Mice were monitored for weight loss, rectal bleeding and general appearance 
(piloerection, lethargy).  Pathology was scored as follows: A) Weight loss, No change = 
0; <5% = 1; 6–10% = 2; 11–20% = 3; >20% = 4; B) Feces, Normal = 0; Pasty, semi-
formed = 2; Liquid, sticky or unable to defecate after five minutes = 4; C) Blood, No 
blood = 0; Visible blood in rectum = 1; Visible blood on fur = 2; D) General appearance, 
Normal = 0; Piloerection = 1; Lethargy and piloerection = 2; Motionless, sickly = 4. 
 
Isolation and preparation of cells 
At necropsy, spleen, MLN, cecal patch, peyer’s patch, were harvested and single-cell 
suspensions were prepared in complete T cell medium (CTCM) (DMEM supplemented 
with 10% heat-inactivated FBS, 2mM glutamine, 100 U/ml penicillin, 100 µg/ml 
streptomycin, 25mM HEPES, and 5 x 10-5 M 2-ME).  If dendritic cells were to be 
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examined, tissues were first minced and incubated in 5 mls of digestive enzyme solution 
(0.5 mg/ml collagenase and 0.05% DNAse in CTCM) for 25 minutes at 37 °C while 
shaking prior to the creation of single-cell suspensions.   
 
Isolation of intraepithelial and lamina propria lymphocytes 
At necropsy, small intestine and large intestine were removed and put into separate Petri 
dishes with pre-warmed CTCM.  Cecal patch and Peyer’s patches were removed and 
placed in 2 mls CTCM on ice.  Intestines were cut longitudinally and feces were removed 
by shaking in a large Petri dish of PBS.  Intestines were further cleaned and mucus 
removed by shaking in a clean Petri dish until PBS remained clear.  Intestines were then 
cut into small sections and placed in 20 mls prewarmed epithelial strip buffer (1mM 
EDTA, 1 mM DTT, 5% fetal bovine serum, 100 U/ml penicillin, 100 µg/ml streptomycin) 
and incubated for 20 minutes at 37 °C while shaking.  Tissue was allowed to settle and 
supernatant was filtered through a cell strainer for isolation of intraepithelial lymphocytes 
(IELs).  Purification of IELs was conducted though utilization of a Percoll gradient.  
Briefly, cells were resuspended in 5 mls of 40% Percoll, underlayed with 70% Percoll, 
and the spun for 20 minutes at 600 g with the brake removed.  Cells were then pipetted 
from the interface and washed twice with CTCM, before resuspending in final volume.  
For isolation of lamina propria lymphocytes (LPLs), intestines were washed with serum-
free media 3 times, and then minced using a razor blade in a small Petri dish.  Intestines 
were then resuspended in 15 mls of digestive enzyme solution (0.5 mg/ml collagenase 
and 0.05% DNAse in CTCM) and incubated for 30 minutes 37 °C while shaking.  The 
entire contents of each tube were then filtered through a cell strainer, and intestines 
were mashed in the cell strainer using the back end of a 3 ml syringe.  The strainers 
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were then washed with 15 mls CTCM.  Cells were then pelleted and washed with CTCM 
before the Percoll purification was preformed as described above.   
 
Flow cytometry and intracellular cytokine staining 
A portion of cells was analyzed ex vivo for cytokine production by stimulating with 10 
µg/ml brefeldin A, 50 ng/ml PMA, and 750 ng/ml ionomycin for 4-5 h.  For DC 
experiments, MLN cells were restimulated in the presence of T. muris ES antigen (50 
µg/ml) and BFA (10 µg/ml).  Cells were then harvested, washed in PBS and stained with 
the fixable aqua blue viability dye (Invitrogen) to assess viability.  Cells were then 
stained with fluorochrome-conjugated antibodies against CD3, CD4, IFN-γ, IL-17A, IL-
10, FoxP3, CD11c, CD8α, CD11b, TNF-α, and IL-12/23p40.  Cells were analyzed by 
flow cytometry on a FACS Calibur or a FACS CANTOII using CellQuest Pro software 
(BD Pharmingen); further analysis was then carried out using FlowJo software (Treestar, 
Inc.).  MLN cells were restimulated by plating cells in medium alone, in the presence of 
T. muris ES Ag (50 µg/ml), or with 1 µg/ml each of soluble α-CD3 and α-CD28 
antibodies.  Following 72 h in culture, cells were stimulated with PMA and ionomycin in 
the presence of brefeldin A for 4-5 h.  Cell-free supernatants were then harvested and 
analyzed for cytokine secretion by sandwich ELISA (eBioscience, San Diego, CA).  The 
cells were then harvested and analyzed for cytokine production as described for the ex 
vivo analysis. 
 
BMDCs and BMDC: T cell co-culture 
Bone marrow derived-dendritic cells (BMDCs) were derived as follows.  Bone marrow 
from WT C57BL/6 mice was plated in 6 well cell culture plates in RPMI 1640 
 104 
supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 5 x 10-5 M 2-ME, 10% 
FBS, 2mM L-glutamine, and 20 ng/ml GM-CSF (Peprotech).  Media was changed at 
days 3, 6 and 8; cells were harvested at day 9.  BMDCs were plated out at 4 x 106 
cells/ml and mixed 1:1 with either media alone, IEC supernatants (CMT-93 cell line), or 
rTSLP (final concentration 10 or 100 ng/ml from R & D), for 16-18 h.  Cells were 
stimulated with LPS (10 ng/ml).  At various time points cell-free supernatants were 
harvested for analysis by ELISA and cells were harvested either for analysis by flow 
cytometry or RT-PCR for mRNA expression.  For BMDC: T cell co-culture, BMDCs were 
harvested and conditioned with CMT-93 supernatants or rTSLP as described above.  
They were then pulsed with 0.5 mg/ml ovalbumin (Worthington) and 1 µg/ml CpG (Coley 
Pharmaceutical Group) for 16-18 h.  Purified OT-II CD4+ T cells were cultured with the 
BMDCs for 4 days.  Cells were stimulated with PMA, ionomycin, and brefeldin A for the 
final 4 h and analyzed by flow cytometry.    
 
Tissue staining 
At necropsy, sections of the proximal large intestine were removed, flushed with PBS, 
and fixed in 4% paraformaldehyde.  5 µm paraffin-embedded sections were cut and 
stained with H&E. 
 
RNA isolation and real-time PCR 
RNA was isolated from intestinal tissues of mice using a Trizol extraction and from 
BMDCs using RNEasy Spin Columns (Qiagen).  Tissues were first disrupted in a tissue 
homogenizer (TissueLyzer, Qiagen).  RNA was extracted from purified cells using 
RNeasy spin columns (Qiagen).  cDNA was synthesized from the isolated RNA using 
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Superscript Reverse Transcriptase (Invitrogen).  Quantitative real-time PCR was carried 
out on cDNA samples using commercial primer sets (Qiagen) and SYBR Green 
chemistry.  All reactions were run on an ABI 7500 Fast Real-Time PCR System (Applied 
Biosystems).  Samples are normalized to naïve controls unless otherwise stated. 
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Results 
Naïve TSLPR-/- mice exhibit increased frequencies of CD4+ IFN-γ+T cells in the 
GALT 
The increased levels of IFN-γ and IL-17A seen in TSLPR-/- mice following Trichuris 
infection is indicative of dysregulated T helper cell differentiation within the GALT.  
Further, IEC-derived TSLP has been previously demonstrated to be important in 
maintaining intestinal immune cell homeostasis (Rimoldi, Chieppa et al. 2005).  To 
investigate whether TSLPR-/- mice have altered homeostasis of intestinal CD4+ T cells, 
cells were isolated from the GALT and large intestine of naïve TSLPR-/- mice and 
TSLPR+/+ controls, and examined ex vivo following PMA/Ionomycin stimulation for 
cytokine production. As the composition of the commensal bacteria within the intestine 
can greatly impact CD4+ IL-17A production (Ivanov, Frutos Rde et al. 2008), 
experiments were performed with littermate control mice raised in the same SPF facility.  
 
A trend towards increased frequencies of CD4+ IFN-γ+ T cells was observed in the MLN 
and CP of TSLPR-/- mice compared to littermate controls (Figure 19A).  This trend was 
most apparent in the MLN and was consistent among three individual experiments (p = 
0.04, p = 0.06, p = 0.1).  Although individual experiments did not reach statistical 
significance in the CP, combined data from 3 experiments representing a total of 10 
mice show a trend towards increased frequencies of CD4+ IFN-γ+ T cells in the TSLPR-/- 
mice compared to TSLPR+/+ mice (p = 0.08).  While slight increases of CD4+ IFN-γ+ T 
cells were observed in the PP and in both the IEL and LPL compartments of the large 
intestine lamina propria of TSLPR-/- mice compared to TSLPR+/+ littermate controls 
(Figure 19A), these numbers did not reach statistical significance (p > 0.1) due to 
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variability within groups and limited cell recovery from the lamina propria.  Although 
preliminary in nature, these results indicate that in the steady state TSLP-TSLPR 
interactions may be playing a role in limiting frequencies of CD4+ IFN-γ+ T cells in the 
GALT.  Frequencies of CD4+ IL-17A+ positive T cells in the GALT were also examined 
and revealed a slight trend towards increased frequencies of CD4+ IL-17A+ T cells in 
TSLPR-/- mice in the MLN, CP, and PP (Figure 19B).  However, these differences did not 
reach statistical signficance (p > 0.1) in any of the three experiments performed.  
Additionally, no differences were detected between TSLPR+/+ and TSLPR-/- mice in either 
the IEL or LPL compartments of the large intestine (Figure 19B).  
 
As dysregulation of IFN-γ could be due to either alteration or impairment of other 
regulatory mechanisms known to be important in the intestine, we also examined the 
frequency of CD4+ IL-10+ and CD4+ FoxP3+ T cells in the GALT of naïve mice.  We 
observed no significant differences in the frequency of CD4+ IL-10+ T cells in TSLPR-/- 
mice compared to TSLPR+/+ littermate controls in the MLN, CP, PP, or the IEL or LPL 
compartments of the large intestine (Figure 20A).  Further, examination of the 
frequencies of CD4+ FoxP3+ T cells in GALT did not reveal any consistent decreases in 
the TSLPR-/- mice in comparison to littermate control TSLPR+/+ mice. (Figure 20B).  
Despite the preliminary nature of this work, these findings indicate that the dysregulation 
of proinflammatory cytokines was not due to an absence of CD4+ FoxP3+ or CD4+ IL-10+ 
cells.  While TSLPR-/- mice do not develop spontaneous colitis, these data suggest that 
even in the steady state, TSLP-TSLPR interactions may play a role in the limitation of 
proinflammatory cytokine production in the intestine. 
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Figure 19 Naïve TSLPR-/- have increased frequencies of CD4+ IFN-γ+ T cells in the 
GALT 
Figure 19.  Naïve TSLPR-/- mice have increased frequencies of CD4+ IFN-γ+ and 
CD4+IL-17A+ cells in the GALT compared to naïve littermate control TSLPR+/+ 
mice.  Cells were isolated from the mesenteric lymph node (MLN), cecal patch 
(CP), peyer’s patch (PP), large intestine intraepithelial lymphoid cells (LI IEL), 
large intestine lamina propria (LI LPL), and are gated on viable, CD3+, CD4+. (A) 
IFN-γ. (B) IL-17A. Numbers are average of CD3+ CD4+ cytokine+ cells from two 
mice per group and are representative of three independent experiments with 2-4 
mice per group. 
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Figure 20 Frequencies of GALT CD4+ IL-10+ and CD4+ FoxP3+ T cells in naïve 
TSLPR-/- mice 
Figure 20. Frequencies of CD4+ IL-10+ and CD4+ FoxP3+ cells in the GALT of 
naïve TSLPR+/+ mice.  Cells were isolated from the mesenteric lymph node (MLN), 
cecal patch (CP), peyer’s patch (PP), large intestine intraepithelial lymphoid cells 
(LI IEL), large intestine lamina propria (LI LPL), and are gated on viable, CD3+, 
CD4+. (A) IL-10. (B) FoxP3. Numbers are average of CD3+ CD4+ cytokine+ cells 
from two mice per group and are representative of two independent experiments 
with 2-4 mice per group. 
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 rTSLP treatment of whole splenocyte cultures results in decreased frequencies of 
CD4+ IFN-γ+ T cells 
The increased frequencies of CD4+ IFN-γ+ T cells in the GALT of naïve TSLPR-/- mice 
suggests that TSLP maybe regulating CD4+ T cell production of IFN-γ.  However, as the 
mice utilized in those experiments have a germ-line deletion of TSLPR, the findings may 
be confounded by developmental defects.  In order to rule out the possibility of any 
confounding developmental defects, an in vitro culture system utilizing WT mice was 
employed.   Splenocytes from WT C57/BL6 mice were cultured for three days in the 
presence or absence of rTSLP.  Cells were cultured with soluble α-CD3/α-CD28 and 
either α-IL-4/α-IFN-γ to stimulate under neutral conditions or α-IL-4/rIL-12 for TH1 
permissive conditions.  Under neutral conditions, the addition of rTSLP decreased the 
frequency of CD4+ IFN-γ+ T cells by a third compared to the untreated control (Figure 
21A).  Examination of the MFI of the IFN-γ+ cells also revealed a decrease with rTSLP 
supplementation, indicating that the cells treated with rTSLP were producing less 
cytokine on a per cell basis compared to cells in the control wells (Figure 21A).  rTSLP 
treatment in the TH1 permissive conditions also resulted in a decrease in both the 
frequency of CD4+ IFN-γ+ cells and the MFI of cytokine positive cells (Figure 21A).  
However, the inhibition of IFN-γ was not as striking as that seen in the neutral conditions.  
In order to ascertain if rTSLP had an impact on IFN-γ protein production under TH1 
polarizing conditions, cell free supernatants were harvested and analyzed by ELISA.  
Treatment with rTSLP significantly decreased the amount of IFN-γ protein secreted into 
the supernatants (Figure 21B), indicating that rTSLP was able to substantially inhibit 
IFN-γ production under TH1 permissive conditions. It remains possible that the inhibition 
of IFN-γ was a secondary result of TSLP’s known ability to drive IL-4 production, which is 
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well known to counter-regulate CD4+ T cell production of IFN-γ.  However, the inhibition 
of IFN-γ occurred in the presence of IL-4 neutralizing mAb in both neutral and TH1 
permissive conditions, indicating another mechanism of action.  Taken together with our 
in vivo findings, these results indicate that rTSLP is able to modulate IFN-γ production by 
CD4+ T cells.   
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Figure 21 Treatment of splenocyte cultures with rTSLP inhibits IFN-γ production 
Figure 21.  Administration of rTSLP inhibits CD4+ IFN-γ production.  Whole 
splenocytes were cultured with soluble αCD3/αCD28, rTSLP was supplemented 
daily at a concentration of 50 ng/ml.  (A) Intracellular cytokine staining of cells 
harvested at day 3. Horizontal numbers indicate frequency of IFN-γ+CD4+ T cells, 
vertical numbers indicated MFI of IFN-γ+ cells.  (B) Cell free supernatants of the 
TH1 polarizing conditions were assayed by ELISA for IFN-γ.  Error bars indicate 
s.e.m.  Data is representative of two independent experiments. 
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TSLP regulates DC production of IL-12/23p40 both in vitro and in vivo 
The dysregulation of CD4+ T cell production of IFN-γ observed in the GALT of TSLPR-/- 
mice both in the steady state and following Trichuris infection suggests a possible 
alteration in signals that influence T helper cell differentiation.  As previous in vitro 
studies demonstrated that TSLP could inhibit IL-12 secretion from human DCs (Al-
Shami, Spolski et al. 2005; Ito, Wang et al. 2005; Rimoldi, Chieppa et al. 2005), we next 
wanted to investigate whether dysregulated IL-12/23p40 production could be playing a 
role early following infection. Analysis of CD11c+ CD11b+ DCs isolated from MLNs of 
infected TSLPR-/- mice showed increased production of the proinflammatory cytokines 
TNF-α and IL-12/23p40 at day 10 post-infection (Figure 22 A, B).  Additionally, levels of 
IL-12/23p40 mRNA were increased in the large intestine of TSLPR-/- mice at day 12 
post-infection (Figure 22C).  These data demonstrate an in vivo role for TSLP in the 
regulation of infection-induced IL-12/23p40 production from intestinal DCs. 
 
To examine the ability of IEC-derived TSLP to modulate DC function, an in vitro 
conditioning system was employed.  Bone marrow-derived DCs (BMDCs) were cultured 
overnight in the presence of supernatants taken from the IEC line CMT-93 (IEC-Sup), 
which is known to express TSLP (Zaph, Troy et al. 2007).  Control and conditioned 
BMDCs were subsequently stimulated with LPS for 8 hours.  Exposure to IEC-Sup did 
not impair the ability of DCs to respond to LPS as IEC-Sup-conditioned BMDCs 
exhibited normal upregulation of surface expression of MHC Class II and the 
costimulatory molecules CD80 and CD86 as compared to unconditioned BMDCs (Figure 
22D).  Further, conditioning with IEC-Sup did not alter or inhibit LPS-induced production 
of TNF-α (Figure 22 E, G).  However, IEC-Sup-conditioned DCs exhibited reduced 
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production of IL-12/23p40 (Figure 22 F, H).  As the IEC-Sup contains multiple IEC-
derived factors, we sought to determine the contribution of TSLP to the regulation of DC 
responses by utilizing recombinant TSLP (rTSLP).  Similar to the results with IEC-Sup, 
exposure of BMDCs to rTSLP did not alter their surface marker expression or production 
of TNF-α following LPS stimulation but did result in decreased IL-12/23p40 production in 
comparison to control treated BMDCs (Figure 22 I-K).  These findings demonstrate the 
ability of TSLP to selectively regulate DC production of IL-12/23p40.  Consistent with 
their inhibition of IL-12/23p40, both IEC-Sup- and rTSLP-conditioned BMDCs induced 
fewer CD4+ T cells to produce IFN-γ in antigen specific co-culture assays (Figure 22L).  
Taken as a whole, these results indicate that TSLP is important in the regulation of DC-
derived IL-12/23p40 both in vitro and in vivo. 
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 Figure 22 TSLP regulates DC production of IL-12/23p40 in vitro and in vivo 
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Figure 22 TSLP regulates DC production of IL-12/23p40 in vitro and in vivo 
Figure 22. TSLP inhibits DC production of IL-12/23p40 in vivo and in vitro. (A-B)  
TSLPR-/- mice have increased DC-derived proinflammatory cytokine production at 
day 10 post-infection.   Cells were isolated from MLN and restimulated directly ex 
vivo with Trichuris ES antigen.  Cells are gated on CD11c+ CD11b+ populations.  
(A) TNF-α, (B) IL-12/23p40.  (C) IL-12/23p40 mRNA expression in the colon at day 
12 post-infection.  (D-F) Supernatants from the IEC CMT-93 cell line specifically 
inhibit LPS-induced IL-12/23p40 production.  (D) LPS-induced upregulation of 
MHC-II, CD80, and CD86.  (E-F) BMDC cytokine production was measured using 
intracellular cytokine staining (ICS).  (E) TNF-α,   (F) IL-12/23p40.  (G-H) Cytokine 
secretion was assayed by ELISA of the supernatants.  (G) TNF-α, (H) IL-
12/23p40.  (I-J) rTSLP specifically inhibits LPS-induced IL-12/23p40 production.  
(I) LPS-induced upregulation of MHC-II, CD80, and CD86.  (J-K) BMDC cytokine 
production as measured using ICS, (J) TNF-α, (K) IL-12/23p40.  (L) IEC and 
rTSLP conditioning of BMDCs decreased CD4+ T cell production of IFN-γ upon co-
culture.  Error bars indicate s.e.m.  A-C represent two individual experiments with 
3 mice per group.  D-K represent three to five individual experiments, L two 
individual experiments. 
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TSLPR-/- mice exhibit an increased susceptibility to DSS-induced colitis 
The dysregulation of DC-derived IL-12/23p40 and CD4+ IFN-γ+ T cells in the intestine 
observed in the TSLPR-/- under both homeostatic and infection-induced settings 
suggests that TSLPR-/- mice may be predisposed to the development of severe intestinal 
inflammation following intestinal damage.  To assess whether the ability of TSLP to 
influence intestinal proinflammatory cytokine extended beyond helminth infection, we 
utilized the dextran sodium sulfate (DSS) model of chemical-induced colitis.  Oral 
administration of DSS is toxic to IECs and induces IEC damage, barrier leakage and 
exposure of sub-epithelial immune cells to commensal bacteria.  Barrier breakdown 
results in immune cell recruitment, increased expression of proinflammatory cytokines, 
and the development of focal ulcerations in the large intestine (Byrne and Viney 2006).   
 
WT and TSLPR-/- mice were exposed to 5% DSS in their drinking water for four days and 
disease was assessed daily.  DSS-treated TSLPR-/- mice exhibited more rapid weight 
loss in comparison to treated WT mice, displaying weight loss as early as day 1 post-
treatment (Figure 23A).  Increased weight loss in the TSLPR-/- mice correlated with early 
disease onset and increased disease severity as measured by fecal consistency, rectal 
bleeding, and general appearance as well as weight loss (Figure 23B).  At day four post-
DSS treatment, sections from the mid colon of DSS-treated WT mice revealed mild 
thickening of the muscularis and minimal presence inflammatory cells.  In contrast, 
tissue sections from DSS-treated TSLPR-/- mice exhibited severe thickening of the 
muscularis, a marked mucosal inflammatory cell infiltrate, and large numbers of focal 
lesions characterized by epithelial cell sloughing, increased inflammatory cell infiltrate 
and loss of crypt architecture (Figure 23C).  Consistent with the increased severity of 
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disease score and inflammation, direct ex vivo organ culture of colonic segments 
displayed increased production of IL-12/23p40 in the DSS-treated TSLPR-/- mice (WT 
0.18 ± 0.05 ng/ml/mg tissue; TSLPR-/- 0.33 ± .08 ng/ml/mg tissue).  Ex vivo analysis of 
MLN cells from day four post-DSS treatment demonstrated an increased number of IFN-
γ+ CD4+ T cells in DSS-treated TSLPR-/- mice compared to WT DSS-treated mice (Figure 
23D).  In addition, polyclonal restimulations of MLN cells harvested at day four post-DSS 
treated TSLPR-/- mice revealed increased levels of IFN-γ in comparison to DSS-treated 
WT mice (Figure 23E).  DSS-treated TSLPR-/- mice also displayed exacerbated colonic 
shortening, thickening, and enteric bleeding at day 6 post treatment compared to DSS-
treated WT mice (Figure 23 F, G). Collectively, these results demonstrate a previously 
unrecognized role for TSLP-TSLPR interactions in the regulation of intestinal 
inflammation in a murine model of IBD. 
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Figure 23 TSLPR-/- mice exhibit an increased susceptibility to DSS colitis 
 
Figure 23. TSLP-TSLPR interactions limit proinflammatory cytokine production and 
inflammation in DSS colitis. (A) Weight loss. (B) Total pathology score for WT and 
TSLPR-/- mice on 5% DSS.  (C) Paraffin-embedded cecal sections from day 4 
post-DSS administration were stained with H&E. Bar, 50 µm. (D) Total number of 
CD4+ IFN-γ+ T cells isolated from the MLN at day 4 post-DSS. (E) Cytokine 
production from anti-CD3 anti-CD28 restimulated MLN cells was determined by 
ELISA.  (F) Colon of day 6 DSS-treated WT and TSLPR-/- mice, Bar, 1 cm. (G) 
Colonic shortening, data are presented as percent length of naïve.  Error bars 
indicate s.e.m. * p ≤ 0.05  ** p ≤ 0.08Data are representative of three individual 
experiments with 4-5 mice per group. 
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Discussion 
Results presented in this chapter highlight a previously unrecognized role for TSLP-
TSLPR interactions in the regulation of proinflammatory cytokine production and 
inflammation within the intestine.  Though TSLPR-/- mice do not develop spontaneous 
colitis, analysis of GALT tissues from naïve TSLPR-/- mice revealed dysregulated DC-
derived IL-12/23p40 production as well as increased frequencies of CD4+ IFN-γ+ T cells, 
indicating dysregulated intestinal immune homeostasis.  The role of TSLP in this 
dysregulation was confirmed as in vitro addition of rTSLP into splenocyte cultures 
resulted in the inhibition of CD4+ T cell IFN-γ production.  Further, TSLP was shown to 
modulate DC-derived IL-12/23p40 both in vitro and in vivo.  The disruption in intestinal 
immune homeostasis in the absence of TSLP-TSLPR interactions has a functional 
consequence, as TSLPR-/- mice exhibited an increased susceptibility to DSS-induced 
colitis.  TSLPR-/- mice displayed increased disease pathology, inflammatory cytokine 
production, and more severe intestinal inflammation compared to DSS-treated WT 
control animals.  Taken together, these findings suggest that in addition to promoting 
TH2 cytokine responses, a function of TSLP in the intestinal microenvironment may be to 
directly and/or indirectly inhibit proinflammatory cytokine production. 
 
Although these data extend the function of TSLP beyond its well-established role in 
directly promoting TH2 cytokine responses, the ability of TSLP to modulate 
proinflammatory cytokine production has been previously indicated.  In vitro studies 
showed TSLP-treated DCs exhibit reduced production of IL-12/23p40 upon TLR ligation, 
and the ability of DC-derived OX40L to drive TH2 cell differentiation is critically 
dependent upon the absence of IL-12 (Soumelis, Reche et al. 2002; Ito, Wang et al. 
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2005; Rimoldi, Chieppa et al. 2005; Zaph, Troy et al. 2007).  In addition, transgenic over-
expression of TSLP in the skin decreased the frequency of CD4+ IFN-γ+ T cells in the 
transgenic mice in comparison to normal littermate controls, and TSLPR-/- mice exhibited 
significantly increased IL-12 mRNA levels in the lungs compared to WT animals 
following OVA-induced allergic inflammation (Al-Shami, Spolski et al. 2005; Yoo, Omori 
et al. 2005). These findings are consistent with a role for TSLP in negatively regulating 
proinflammatory cytokine production in DC populations in peripheral sites.  Thus the 
exaggerated TH2 cytokine-mediated diseases in mice with transgenic over-expression of 
TSLP may be a result of simultaneous increases in TH2 cytokine responses and 
decreased expression of proinflammatory cytokines including IL-12 and IFN-γ that would 
counter-regulate developing TH2 cytokine responses.   
 
While our results highlight the ability of TSLP to modulate proinflammatory cytokine 
production in the intestine, the exact mechanisms of action and molecular pathways 
involved remain unclear.  As TSLPR is functionally expressed on a variety of cell types 
including DCs, mast cells, basophils, and CD4+ T cells (see Chapter 2), it is not known if 
TSLP is acting either directly, or indirectly to modulate CD4+ T cell IFN-γ production.  
TSLP may be acting indirectly through DCs, as TSLP-treatment of DCs inhibits IL-
12/23p40 production in a manner that results in decreased production of IFN-γ from co-
cultured CD4+ T cells (Figure 23L).  Although the ability of TSLP to inhibit DC production 
of IL-12/23p40 has been well documented (Soumelis, Reche et al. 2002; Ito, Wang et al. 
2005; Rimoldi, Chieppa et al. 2005; Zaph, Troy et al. 2007), the signaling pathways 
induced by TSLP in DCs to regulate gene expression are unknown at present.  
Additionally, TSLP treatment of DCs may influence intestinal cytokine production by 
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altering the composition of immune cell populations within the intestine.  As TSLP-
treatment of DCs is known to induce expression of the TH2 cell-attracting chemokine 
CCL20, and the T cell-attracting chemokine CCL17 (Reche, Soumelis et al. 2001; 
Soumelis, Reche et al. 2002), TSLP could be increasing the recruitment of non-IFN-γ 
producing T cells to the intestine.   
 
TSLP may also act directly on CD4+ T cells to limit TH1 cell differentiation. Although 
rTSLP was shown to inhibit CD4+ T cell production of IFN-γ in the absence of IL-4 
(Figure 21), it remains possible that TSLP is regulating IFN-γ production through its 
promotion of TH2 cytokine responses.  TSLP is known to promote expression of GATA-3 
and IL-4 in CD4+ T cells (Omori and Ziegler 2007); pathways that inhibit expression of 
IFN-γ (Murphy and Reiner 2002; Szabo, Sullivan et al. 2003).  Direct inhibition of CD4+ T 
cell IFN-γ production may also be possible.  For instance, TSLP activates STAT5 
(Isaksen, Baumann et al. 1999; Levin, Koelling et al. 1999), and STAT5a activation in 
CD4+ T cells has been shown to inhibit IL-12-induced STAT4 activation through the 
induction of SOCS3 (Takatori, Nakajima et al. 2005).  However, it remains unknown 
which of these pathways, if any, contribute to the ability of TSLP to decrease CD4+ T cell 
production of IFN-γ.   
 
TSLP may also act indirectly through innate cell production of IL-4 to influence CD4+ T 
cell production of IFN-γ.  In conjunction with other cytokines, TSLP has been shown to 
induce mast cell production of TH2 cytokines (Soumelis, Reche et al. 2002; Allakhverdi, 
Comeau et al. 2007; Allakhverdi, Smith et al. 2007; Okayama, Okumura et al. 2009), 
indicating mast cells could represent an important source of IL-4.  However, as mast 
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cells are not normally present within the GALT at high frequencies, and TSLP-induced 
TH2 cytokine production requires the presence of additional cytokines, it is possible that 
mast cell-derived IL-4 plays a more important role in the inhibition of CD4+ T cell IFN-γ 
production under situations of inflammation or infection.  Further studies must be done to 
determine the relative importance of TSLP acting either indirectly through DCs and/or 
mast cells, or directly through CD4+ T cells, to inhibit CD4+ T cell production of IFN-γ.  It 
is important to note that these possibilities are not mutually exclusive and that it is 
feasible that TSLP is utilizing multiple mechanisms to limit proinflammatory cytokine 
production and inflammation in the intestine. 
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CHAPTER 5: Discussion and Future Directions 
 
Introduction 
It has been fifteen years since the biological activity of TSLP was first described (Friend, 
Hosier et al. 1994) and ten years since the genes for both TSLP and TSLPR were 
cloned and sequenced (Park, Martin et al. 2000; Sims, Williams et al. 2000; Quentmeier, 
Drexler et al. 2001).  Despite numerous and significant advances in understanding the 
role of TSLP in lymphoid development and in the promotion of TH2 cytokine-mediated 
inflammation in the skin and the lung (see Chapter 1), the understanding of the role of 
TSLP in the intestinal immune system is still in its infancy.  While expression of TSLP 
mRNA was noted in the ileum of the small intestine in 2000 (Sims, Williams et al. 2000), 
a function for TSLP in the intestine was not proposed until 2005 when Rescigno and 
colleagues demonstrated that TSLP was important in maintaining intestinal immune 
hyporesponsiveness through the promotion of TH2 cell differentiation (Rimoldi, Chieppa 
et al. 2005).  Despite advances in identifying both TSLP-expressing and TSLP- 
responsive cell populations in vitro, the relevant cellular sources and targets of TSLP in 
vivo remain largely unknown.  In addition to these more basic questions, the biological 
function of TSLP-TSLPR interactions within the intestine has also not been fully defined.  
At the onset of this thesis, it was unknown if TSLP was critically required for the 
development of host-protective intestinal TH2 cytokine-mediated immune responses, or if 
the function of TSLP in the intestinal microenvironment extended beyond its ability to 
promote TH2 cytokine responses.  Within this context, it was the goal of this thesis to 
begin to define and characterize the role of TSLP-TSLPR interactions in regulating 
intestinal immunity and inflammation.   
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Summary, discussion, and future directions 
TSLP and TSLPR complex expression in the intestine 
In Chapter 2 of this thesis, in order to achieve a more comprehensive understanding of 
the cellular components of TSLP-mediated regulation in the intestine, I characterized the 
cellular sources and targets of TSLP in the large intestine and GALT.  Further, I 
determined the functionality of TSLPR complex expression on GALT-derived CD4+ T 
cells and CD11c+ DCs.  From these studies, we demonstrated that under naïve 
homeostatic conditions, the dominant source of TSLP within the large intestine is IECs 
(Figure 5).  Further, we found that surface expression of TSLPR complex is extensive 
throughout tissues of the GALT, being detected on CD11c+ DCs, CD4+ T cells, as well 
as the innate cell populations of basophils and mast cells (Figures 6-8).  Also, we 
demonstrated that both CD11c+ DCs and CD4+ T cells from the GALT can respond to 
TSLP and upregulate phosph-STAT5 directly ex vivo without additional activation or 
stimulation (Figure 9).   
 
Regulation of TSLP expression in the intestine 
The constitutive expression of TSLP from IECs in the large intestine is consistent with 
previous findings (Rimoldi, Chieppa et al. 2005), however the cellular signals that 
mediate or induce this expression remain unidentified.  In vitro studies have 
demonstrated that TSLP production from epithelial cells can be elicited by external 
factors such as TLR ligands and viruses as well as by host-derived factors such as 
cytokines (Saenz, Taylor et al. 2008), making it difficult to distinguish the relevant signals 
driving TSLP expression within the intestinal tract.  The elevated expression of TSLP in 
the large intestine compared to the small intestine or cecum correlates with the 
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increasing population size of commensal bacteria in the distal portions of the GI tract.  
This makes it tempting to speculate that TSLP expression, may, at least in part, be 
driven by commensal-derived signals.  However, preliminary studies comparing TSLP 
mRNA expression in large intestine tissue between conventionally housed mice and 
germ free mice showed no significant alteration in expression between experimental 
groups (Colby Zaph, personal communication, and data not shown), indicating that 
commensal-derived signals may not be essential for intestinal TSLP expression.  These 
findings do not entirely rule out external stimuli in driving IEC TSLP expression, 
however, since sterilized mouse chow has been found to contain detectable levels of 
bacterial DNA (David Hill, personal communication), which could act as a stimulatory 
signal for TSLP expression in germ-free mice.   Finally, it is possible that food antigens 
or the mechanical act of digestion and smooth muscle contraction could stimulate TSLP 
production by IECs.    
 
In addition to externally-derived signals, host-derived cytokines could also play a role in 
stimulating TSLP expression in the intestine.  As the intestine is an active immunologic 
site, continually being stimulated by environmental, food, and commensal bacteria-
derived antigens, the steady state production of cytokines within the intestine could be 
sufficient to induce TSLP expression.  Although many possible cytokine candidates 
exist, TSLP was induced following Trichuris infection in SCID mice (Humphreys, Xu et 
al. 2008), indicating an innate cell source.  Additionally, IECs themselves must be 
considered as a source of factors that could regulate TSLP expression.  It is possible 
that IEC-derived products could be acting in an autocrine fashion to induce constitutive 
TSLP expression.  It is important to note that the possible mechanisms to stimulate IEC 
 127 
TSLP production are not mutually exclusive and that that many factors may act to 
regulate expression of TSLP within the intestine.  
 
Although IECs appear to be the main source of TSLP within the intestine, recent work 
has indicated that innate cells may also represent a source of TSLP.  Studies have 
demonstrated that mast cells upregulate both TSLP mRNA and protein following FcεRI 
cross-linking (Soumelis, Reche et al. 2002; Okayama, Okumura et al. 2009).  
Additionally, basophils upregulate both TSLP mRNA and protein following stimulation 
with papain (Sokol, Barton et al. 2008).  As both mast cells and basophils require 
stimulation to produce TSLP (Allakhverdi, Comeau et al. 2007; Sokol, Barton et al. 
2008), it remains possible that they only function as sources of TSLP in situations of 
infection and/or inflammation.  Also, as mast cells and basophils are normally present at 
very low frequencies within the lamina propria and GALT, infection and/or inflammation-
derived signals may be required to recruit enough of these cells into the tissues to 
become a physiologically relevant source of TSLP.  Given the recently discovered 
importance of antigen presenting basophils in the initiation of TH2 cytokine immune 
responses (Perrigoue, Saenz et al. 2009; Sokol, Chu et al. 2009; Yoshimoto, Yasuda et 
al. 2009), it is possible that basophil-derived TSLP may play an important role in the 
initiation of intestinal TH2 immune responses.  However, more studies will need to be 
done to determine if basophil-derived or mast cell-derived TSLP is sufficient to influence 
intestinal immune responses, and if its expression can be controlled or regulated. 
 
Cellular targets of TSLP and regulation of TSLPR expression 
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Identification of the cellular targets of TSLP has been hindered by a lack of reagents that 
are able to specifically and reliably detect surface protein expression of the TSLPR-α 
chain of the TSLPR complex. Previous studies have largely been limited to the 
examination of either TSLPR mRNA expression in whole tissues, cell lines, or in purified 
populations or by in vitro binding assays (Park, Martin et al. 2000; Reche, Soumelis et al. 
2001; Allakhverdi, Comeau et al. 2007).  Our findings of surface expression of TSLPR-α 
chain on GALT CD11c+ DCs and mast cells are consistent with the published literature 
(Reche, Soumelis et al. 2001; Soumelis, Reche et al. 2002; Rimoldi, Chieppa et al. 
2005; Allakhverdi, Comeau et al. 2007); however, we extended these findings by 
demonstrating co-expression of the second, critically required chain of the heterodimeric 
TSLPR complex, CD127 (IL-7Rα) on these cell populations (Figure 6, 7).  We also show 
that in addition to being cellular sources of TSLP (Sokol, Barton et al. 2008), basophils 
express the TSLPR complex (Figure 6).  Our characterization of TSLPR complex 
expression in the GALT also revealed functional receptor surface expression on CD4+ T 
cells directly ex vivo.  These findings are inconsistent with in vitro studies on human 
CD4+ T cells, which showed no surface expression on freshly isolated cells (Rochman, 
Watanabe et al. 2007; Lu, Wang et al. 2009).  Although the source of the discrepancy is 
unknown, it is possible that there is species-specific regulation of TSLPR expression.  
Alternatively, the sensitivity of the reagents utilized in the studies could be different.  
Nonetheless, our data showing CD4+ T cell phospho-STAT5 activation following TSLP 
treatment indicate that within the murine model, the possibility of TSLP acting directly on 
naïve CD4+ T cells must be taken into account.   
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Although we have a basic understanding of the factors than can regulate TSLP 
expression (Chapter 1), very little is known about the factors that regulate TSLPR 
complex expression.  On the cellular level, work focusing on human CD4+ T cells found 
upregulation of the TSLPR-α chain following polyclonal activation (Rochman, Watanabe 
et al. 2007; Lu, Wang et al. 2009).  Studies examining TSLPR mRNA expression in 
whole tissues indicate that TSLPR expression is dynamically regulated during the course 
of helminth infection (Humphreys, Xu et al. 2008; Ramalingam, Pesce et al. 2009).  
However, due to the nature of these studies it is not known if the regulation of TSLPR 
expression was mediated directly by the pathogen, or was a result of the immune 
response following infection.  Our in vitro findings utilizing BMDCs suggest that both 
methods of regulation may be possible as TSLPR expression was upregulated following 
treatment with helminth-derived products as well as with both pro- and anti-inflammatory 
cytokines (Figure 6).  However, as treatment with LPS and CpG did not mediate TSLPR 
upregulation in BMDCs (Figure 6) and TSLPR expression has not been examined 
following infection with either bacterial or viral pathogens, it is possible that the ability of 
pathogens to modulate TSLPR expression is restricted to helminths.  Treatment of 
BMDCs with papain induced TSLPR upregulation, indicating that the TSLPR complex 
may also be dynamically regulated in allergic responses.  While these findings begin to 
hint at the signaling pathways that could potentially be involved, the exact mechanisms 
and mediators remain unknown, and it is unclear whether regulation of receptor 
expression differs between cell types.   
 
Future directions and challenges 
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As TSLP is a relatively new cytokine, many basic and fundamental questions remain 
unanswered regarding both its production and cellular targets.  Much of the work done 
characterizing the factors that regulate TSLP expression has been done in vitro, and the 
physiologic relevance of these findings remains to be determined.  Further, it is unclear 
how the inherently different microenvironments of the skin, lung, and intestine influence 
either epithelial or innate cell production of TSLP.  Recent advances in the development 
of reliable reagents to detect TSLPR-α chain surface expression have begun to allow 
analysis of target cell populations directly ex vivo.  Despite this, it is unknown what role, 
if any, TSLPR regulation plays in modulating immune responses in vivo.  Future studies 
focusing on TSLP and TSLPR expression must move in vivo to extrapolate the 
physiologically relevant signals that both positively and negatively regulate expression. 
 
In addition to defining regulatory signals for both TSLP and TSLPR expression, a more 
in depth understanding of the TSLP signaling pathway is needed.  The current 
understanding of TSLP signaling is limited (Sebastian, Borowski et al. 2008), with the 
kinases and target genes largely unresolved.  Further, the majority of the studies 
examining TSLP signaling were conducted in cell lines transfected with components of 
the TSLPR, or in cell types that are now known to not be physiologically relevant targets 
of TSLP (Isaksen, Baumann et al. 1999; Levin, Koelling et al. 1999; Isaksen, Baumann 
et al. 2002).  Thus it is difficult to ascertain the relevance of these findings and 
understand how it relates to TSLP signaling in primary cells.  Also, it is unknown if TSLP 
signaling varies from one cell population to another, which, given the numerous 
downstream functions attributed to TSLP signaling, seems likely.  For instance, while 
TSLP alone is sufficient to influence DC function (Reche, Soumelis et al. 2001; 
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Soumelis, Reche et al. 2002), treatment with TSLP alone does not impact mast cell 
function (Allakhverdi, Comeau et al. 2007).  Despite constitutive TSLPR complex 
expression (Figure 7 and (Allakhverdi, Comeau et al. 2007)), mast cells require 
sensitization with either IL-1, TNF-α, or IL-33 for TSLP to induce TH2 cytokine release 
(Allakhverdi, Comeau et al. 2007; Allakhverdi, Smith et al. 2007).  The mechanism 
behind this regulation is not clear.  It is possible that the sensitization signal results in the 
de-repression of TSLP signaling, or that it alters the abundance of the required 
downstream signaling molecules.  Further studies must be conducted focusing on 
TSLPR signaling in multiple cell types. 
 
Although much progress has been made in understanding the functional biology of 
TSLP, it remains important to address fundamental questions regarding the regulation of 
both the ligand and the receptor.  Additionally, the current limitations in the 
understanding of TSLP signaling make it difficult to identify and assess potential cross 
regulation from other cytokines.  Answering these questions will be key to understanding 
the biology of TSLP in the intestine as well as in other tissues.  Further, these findings 
may help identify components of the regulatory network that could potentially be 
exploited for therapeutic benefit.      
 
The role for TSLP in intestinal TH2 cytokine-mediated immune responses 
In Chapter 3, I directly tested the hypothesis that TSLP-TSLPR interactions would be 
required for the development of a host-protective TH2 cytokine-mediated immune 
response in the intestine utilizing infection with the model GI nematode pathogen 
Trichuris.  From these studies, we demonstrated that while TSLP-TSLPR interactions 
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are required for immunity to Trichuris, TSLP-independent TH2 cytokine responses 
developed in the absence of IFN-γ (Figure 17).  These findings demonstrate that TSLP is 
not critically required for the initiation of TH2 cytokine responses in the intestine.   
 
The requirement for TSLP in infection-induced TH2 cytokine responses 
Although TSLP is important in both the initiation and promotion of allergic TH2 cytokine-
mediated inflammation in the skin and lung (Liu 2006; Liu, Soumelis et al. 2007), our 
findings indicate that TSLP is not critically required for the initiation of an infection-
induced TH2 cytokine response in the intestine (Chapter 3).  While it remains possible 
that tissue-specific differences exist in terms of TSLP function, more recent work 
suggests that the requirement for TSLP in the initiation and promotion of TH2 cytokine 
responses varies between situations of allergy and infection.   
 
In addition to our findings, TSLP-independent intestinal TH2 cytokine responses have 
also been documented in situations of infection.  TSLPR-/- mice were demonstrated to 
mount TH2 cytokine responses following infection with the intestinal dwelling helminth 
Heligmosomoides polygyrus (H. polygyrus) (Massacand, Stettler et al. 2009).  Further, 
TSLPR-/- mice exhibited intact TH2 cytokine-mediated immunity to infection with 
Nippostrongylus brasiliensis (N. brasiliensis), a helminth pathogen with an intestinal 
phase of infection (Massacand, Stettler et al. 2009).  Also, TSLP does not appear to be 
required for infection-induced TH2 cytokine responses in the liver or lung.  Although 
TSLPR-/- mice infected with Schistosoma mansoni (S. mansoni) cercariae exhibited 
reduced production of IL-13 and decreased liver fibrosis at 9 weeks post infection 
compared to WT controls, TSLPR-/- mice produced equivalent levels of IL-4 and IL-5 to 
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WT mice.  Also, TSLPR-/- mice still developed chronic infection and exhibited TH2-
cytokine-dependent pathology in the liver that was indistinguishable from WT mice at 12 
weeks post-infection (Ramalingam, Pesce et al. 2009).  The role of TSLP in pathogen-
induced airway inflammation was investigated utilizing infection with N. brasiliensis, 
whose migration through the lung induces TH2 cytokine-mediated inflammation and 
pathology. TSLPR-/- mice infected with N. brasiliensis not only cleared both primary and 
secondary infections, but also developed TH2 cytokine responses, and TH2 cytokine-
dependent lung inflammation comparable to WT control mice (Massacand, Stettler et al. 
2009).   
 
Overall, these studies focusing on the role of TSLP in infection indicate that while TSLP 
may be important for optimal responses, it is not strictly required for the development of 
infection-induced TH2 cytokine responses.  These data support the hypothesis that TSLP 
is required in allergen-driven TH2 cytokine responses, but not in situations of infection.  
However within the intestine, the corollary of TSLP involvement in allergen-driven 
responses remains unknown.  As food allergy is associated with intestinal TH2 cytokine 
immune responses (Nagler-Anderson 2001; Devereux 2006), we hypothesize that TSLP 
will be important in food allergen-associated immune responses.   
 
Allergy versus infection 
It remains unclear why TSLP is differentially required in situations of allergy-driven TH2 
cytokine responses and infection-induced TH2 cytokine responses.  Although allergic 
responses and the subsequent TH2 cytokine-mediated inflammation are pathological, 
and infection-induced TH2 cytokine responses are usually host-protective, the line 
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between protective and pathologic becomes blurred when examining chronic helminth 
infections such as S. mansoni.  TSLPR-/- mice still develop severe TH2 cytokine-
dependent pathology in the liver following S. mansoni infection (Ramalingam, Pesce et 
al. 2009).  Ramalingam et al. propose that the different routes of Ag exposure may be 
sufficient to explain the difference between the requirement for TSLP in allergy and 
infection.  As opposed to allergens, which primarily interact with epithelial cells at 
mucosal surfaces, helminth infection usually results in Ag exposure in and damage to 
multiple tissues as a result of parasite migration and maturation.  It is possible therefore, 
that the increased damage and more systemic level of stimulation triggers other TH2 
cytokine-inducing factors, alleviating the need for TSLP (Ramalingam, Pesce et al. 
2009). 
 
This hypothesis of altered route of Ag exposure and increased tissue damage is also 
consistent with the observed differences in the requirement for TSLP in TH2 cytokine 
responses between infection with H. polygyrus and Trichuris.  TSLP is not required for 
the generation of a TH2 cytokine response to infection with H. polygyrus (Massacand, 
Stettler et al. 2009), whose life cycle requires penetration of the intestinal submucosa 
and migration through intestinal muscle tissue (Finkelman, Shea-Donohue et al. 1997).  
In contrast, TSLP is required for TH2 cytokine-mediated immunity to Trichuris (Chapter 3, 
(Massacand, Stettler et al. 2009), whose life cycle is entirely enteric, with worms only 
embedding their anterior ends within the epithelial cell layer of the intestine, never 
penetrating the submucosa or the muscle (Cliffe and Grencis 2004).  Thus, it is possible 
that TSLP is required in response to Trichuris infection because the life cycle of the 
worm does cause sufficient tissue damage or Ag exposure outside of the intestinal 
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epithelium to trigger other TH2 inducing factors.  Although more work needs to be done 
to determine the reason for the differential requirement of TSLP in allergen-induced and 
infection-induced TH2 cytokine responses, it is possible that signals derived from 
infection-induced tissue damage may play a role.   
 
The functional biology of TSLP in Trichuris infection 
The demonstration that TSLPR-/- mice are capable of mounting TH2 cytokine responses 
to N. brasiliensis and H. polygyrus raises the question about the differential requirement 
for TSLP in Trichuris infection.  As TSLP is not required for the initiation of TH2 cytokine 
responses in other intestinal infections (Massacand, Stettler et al. 2009), it must serve 
another function during Trichuris infection important in the creation of a TH2 permissive 
microenvironment.  Work from Massacand et al. pinpoints the importance of TSLP in the 
inhibition of DC-derived IL-12/23p40 in Trichuris infection.  While ES products from N. 
brasiliensis and H. polygyrus inhibit BMDC production of IL-12/23p40, ES products from 
Trichuris fail to block DC-derived IL-12/23p40 in vitro.  Blockade of IL-12/23p40 in vivo 
during Trichuris infection is sufficient to restore immunity to TSLPR-/- mice (Massacand, 
Stettler et al. 2009).   
 
Taken together with our findings, these data suggest that primary function of TSLP in 
Trichuris infection is to inhibit proinflammatory cytokine production, as TSLP-
independent mechanisms are sufficient to drive TH2 cytokine responses in the absence 
of the TH1-associated cytokine IL-12/23p40 and IFN-γ.  Thus, in comparison to N. 
brasiliensis and H. polygyrus, Trichuris lacks the ability to modulate the intestinal 
immune response, and requires TSLP to take the place of a pathogen-derived factor to 
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limit proinflammatory cytokine production and create a TH2 permissive 
microenvironment. 
 
Although TSLP is not required for the development of protective immunity to Trichuris in 
the absence of proinflammatory cytokines, the relevant cellular sources and targets of 
TSLP during infection remain undefined.  Though IECs appear to be the dominant 
source of TSLP in the intestine, basophil and mast cell production of TSLP have been 
reported (Sokol, Barton et al. 2008; Okayama, Okumura et al. 2009).  As discussed 
previously, it is possible that basophils and mast cells could be physiologically relevant 
sources of TSLP over the course on an infection.  To address this issue, chimeric 
studies must be carried out to delineate the importance of haematopoietic versus non-
haematopoietic cell expression of TSLP in vivo.  Further, as previous work has been 
completed with germ line knockouts of TSLPR, we do not know the function or relative 
importance of TSLP acting on individual cell populations in vivo.   While the studies from 
Massacand et al. indicate that DCs are the pertinent target cell population in Trichuris 
infection (Massacand, Stettler et al. 2009), our studies indicate that CD4+ T cells also 
express functional TSLPR complex (Figure 6) and could represent an additional cellular 
target, either for the inhibition of proinflammatory cytokine production (Figures 13, 16, 
19), or for the initiation of TH2 cytokine production (Omori and Ziegler 2007).  To address 
whether CD4+ T cell restricted or accessory cell restricted TSLPR expression is sufficient 
to promote a TH2 cytokine response to Trichuris, transfer studies isolating TSLPR 
expression on CD4+ T cells or accessory cells need to be carried out.  Understanding of 
the relative contribution and importance of TSLP signaling on each cell type in vivo is 
important in understanding the complexity of the functional biology of TSLP. 
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Future directions and challenges 
The finding of TSLP-independent infection-induced TH2 cytokine responses suggests 
that the concept that TSLP plays a central role in all TH2 cytokine responses (Liu, 
Soumelis et al. 2007) must be reevaluated.  The demonstration of a differential 
requirement for TSLP in the initiation of allergen versus infection-induced TH2 cytokine 
response indicates that the functional biology of TSLP varies dependent on the 
immunological context. The fundamental differences between situations of allergy and 
infection that influence the requirement for TSLP in the initiation of TH2 cytokine 
responses remain to be elucidated.  Studies examining increased routes of allergen 
exposure and coupling allergen exposure with tissue damage must be done to dissect 
the importance of increased Ag exposure or infection-induced tissue damage in the 
TSLP independence of infection-induced TH2 cytokine responses (Ramalingam, Pesce 
et al. 2009) these factors.  Additionally, to examine the possibility that tissue-specific 
factors can influence the requirement for TSLP in allergic responses, the role of TSLP in 
food allergy must be investigated.  Although we hypothesize that TSLP will be required 
for the generation of a food allergen-induced TH2 cytokine response, the distinct 
microenvironment of the intestine may be able to compensate for the loss of TSLP, 
resulting in a TSLP-independent TH2 cytokine response.   
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TSLP and the regulation of proinflammatory cytokine production and 
inflammation in the intestine 
In Chapter 4 I investigated the hypothesis that TSLP was important in the regulation of 
proinflammatory cytokine production and inflammation within the intestine.  Consistent 
with this, naïve TSLPR-/- mice were found to have dysregulated production of DC-
derived IL-12/23p40 and CD4+ T cell derived IFN-γ in the GALT (Figures 19, 21).  
Further, in vitro studies indicate that TSLP maintains the ability to regulate CD4+ T cell 
IFN-γ production in the absence of IL-4 (Figure 20).  While it is not clear whether TSLP is 
acting solely through DCs to modulate CD4+ T cell IFN-γ production, TSLP regulates 
DC-derived IL-12/23p40 both in vitro and in vivo (Figure 22).  Although the dysregulation 
of proinflammatory cytokines in the GALT does not lead to spontaneous colitis, TSLPR-/- 
mice display an increased susceptibility to DSS-induced colitis, exhibiting increased 
proinflammatory cytokine production and more severe intestinal inflammation compared 
to WT control mice (Figure 23).   
 
TSLP and the regulation of epithelial cell barrier function 
Recent evidence suggests that TSLP could contribute to the regulation of intestinal 
inflammation by impacting barrier function.  In vitro studies utilizing human nasal 
epithelial cells (HNECs), found that TSLP treatment upregulated the tight junction 
proteins claudin-1, -4, -7, and occludin within 6 -24 hours.  Further, TSLP treatment 
impacted barrier function as TSLP-treated HNECs showed significantly increased 
transepithelial electrical resistance (TER), and decreased permeability of larger 
molecular weight molecules (Kamekura, Kojima et al. 2009).  As TSLPR-α chain was not 
found to be expressed on HNECs or human nasal mucosa in vivo (Kamekura, Kojima et 
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al. 2009), the changes in barrier permeability most likely did not result from TSLP-
TSLPR signaling on the epithelial cells.  However, these findings still indicate that TSLP 
can influence epithelial cell barrier function through an unknown mechanism.   
 
It is possible that TSLP-mediated regulation of barrier function extends into the intestine, 
and that TSLP may play an important role in barrier maintenance.  Crohn’s disease is 
characterized by compromised barrier function and the development of immune 
responses directed against commensal bacteria (Xavier and Podolsky 2007).  
Interestingly, loss of TSLP expression is observed in intestinal biopsies from Crohn’s 
disease patients (Rimoldi, Chieppa et al. 2005).  It remains possible that the loss of 
TSLP expression observed in Crohn’s disease could contribute to the increased barrier 
permeability and bacterial translocation that results in immune cell activation and 
inflammation. 
 
TSLP in the maintenance of immune homeostasis 
Our findings of dysregulated intestinal proinflammatory cytokine production in the 
absence of TSLPR are consistent with work from Rescigno and colleagues which 
identified a role for TSLP in the maintenance of intestinal immune homeostasis (Rimoldi, 
Chieppa et al. 2005). As the intestinal microenvironment is constantly being 
immunologically stimulated by both food-derived and commensal bacteria-derived 
antigens (Chapter 1), TSLP may have developed as a regulatory mechanism to prevent 
the development of inflammation resultant from continual stimulation.  However, the lack 
of spontaneous colitis in TSLPR-/- mice indicates TSLP is not as central to maintaining 
intestinal homeostasis as IL-10, whose deletion results in spontaneous disease (Strober, 
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Fuss et al. 2002; Elson, Konrad et al. 2004).  Instead, TSLP in the intestine may be one 
of the many partially redundant immunoregulatory factors that act to maintain 
hyporesponsiveness and homeostasis.   
 
Currently, it remains undetermined if the ability of TSLP to regulate proinflammatory 
cytokine production extends beyond the intestine to include other tissues.  While there 
have been indications of TSLP-mediated regulation of proinflammatory cytokine 
production in both the skin and the lung (Al-Shami, Spolski et al. 2005; Yoo, Omori et al. 
2005), the anti-inflammatory role of TSLP in these tissues has not yet been directly 
examined.  As the level of antigenic stimulation and burden of commensal bacteria is 
substantially reduced in the skin and the lung, TSLP may not be required for, or 
important in, the maintenance of immune cell homeostasis in these tissues.   
 
The increased susceptibility of TSLPR-/- mice to DSS-induced colitis suggests that 
TSLPR-/- mice may also have heightened TH1 cytokine responses, possibly increasing 
their resistance to bacterial or viral pathogens.  The immunobiology of TSLP in intestinal 
infections that require TH1 cytokine responses for immunity such as Salmonella 
(Monack, Mueller et al. 2004; Coburn, Grassl et al. 2007) remains unknown.  Our 
findings suggest that TSLPR-/- mice would be predisposed to intestinal CD4+ T cell IFN-γ 
production upon infection, possibly increasing resistance and resulting in a faster kinetic 
of bacterial clearance.  However, it is also possible that the predisposition and increased 
IFN-γ response may lead to unregulated immune-mediated pathologies and death of the 
TSLPR-/- mice.  It will also be important to determine if TSLPR-/- mice have systemically 
dysregulated TH1 cytokine responses.  Studies with TH1 cytokine-inducing parasitic 
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infection models such as Leishmania major, which can be localized to the footpad or ear, 
or intraperitoneally injected Toxoplasma gondii which results in systemic infection, have 
also not been done.  Understanding the role of TSLP in TH1 cytokine responses is 
important as it might impact susceptibility or resistance to infection in human diseases 
where TSLP expression is dysregulated, such as Crohn’s disease (Rimoldi, Chieppa et 
al. 2005) or asthma (Ying, O'Connor et al. 2005).   
 
Future directions and challenges 
Taken together, our studies suggest an important role for TSLP in the regulation of 
intestinal inflammation.  However, as the majority of studies completed on TSLP to date 
focus on the TH2 promoting functions of TSLP, many basic questions concerning TSLP-
mediated regulation of proinflammatory cytokine production remain unanswered.  The 
mechanisms and molecular mediators involved remain undefined, and it is unclear 
whether the mechanisms very between homeostatic conditions and situations of 
infection or inflammation. 
 
Understanding whether TSLP’s ability to inhibit proinflammatory cytokine production is a 
tissue-specific function restricted to the intestine is of critical importance if the TSLP-
TSLPR pathway is to be manipulated for therapeutic benefit.  While studies have 
indicated a therapeutic benefit to blocking either TSLP (Miyata, Nakamura et al. 2009) or 
OX40-OX40L interactions (Seshasayee, Lee et al. 2007; Wang and Liu 2007) in 
situations of atopy, our findings indicate that systemic targeting of TSLP may lead to a 
predisposition to develop inflammation within the intestine.  The potential for negative 
consequences resulting from systemic targeting of the TSLP-TSLPR pathway highlight 
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the importance of fully characterizing the functionality of TSLP in each tissue.  Although 
TSLP appears to be predominately associated with pathologic TH2 cytokine responses in 
the skin and lung, the possible immunoregulatory function of TSLP in these tissues must 
not be discounted.   
 
Concluding remarks 
The results presented in this thesis provide new insights into the role that TSLP-TSLPR 
interactions play in regulating immunity and inflammation within the GI tract (summarized 
in Figure 24).  Data presented in Chapter 2 reveal the complex nature of TSLP-TSLPR 
interactions within the intestine, as cells of both the innate and adaptive immune system 
express the TSLPR complex and respond to TSLP stimulation.  In Chapter 3 we 
investigate the functional biology of TSLP in intestinal infection and identify TSLP-
independent host-protective TH2 cytokine responses, demonstrating that TSLP is not the 
critical factor required for the initiation of TH2 immune responses.  The potential 
regulatory function of TSLP is explored in Chapter 4.  We demonstrate that TSLP is 
important in the maintenance of intestinal immune homeostasis and can regulate 
proinflammatory cytokine production in vitro and in vivo.  Collectively these studies 
identify an important role for TSLP-TSLPR interactions in the regulation of the intestinal 
immune system and provide insights into how this pathway could be manipulated for 
therapeutic benefit when the balance of immunity and inflammation in the intestine is 
disrupted.   
 
 143 
Figure 24 TSLP is a central regulator of intestinal immune homeostasis 
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Figure 24 TSLP as a central regulator of intestinal immune homeostasis 
Figure 24 TSLP-TSLPR interactions are important in the maintenance of intestinal 
immune homeostasis.  TSLP is produced by IECs and acts on DCs to promote TH2 
cell differentiation and inhibit TH1 cell differentiation, partially through the inhibition 
of DC-derived IL-12/23p40.  TSLP acts directly on naïve CD4+ T cells to promote 
TH2 cell differentiation and potentially inhibit IFN-γ production.  TSLP acts on mast 
cells in conjunction with other cytokines to induce TH2 cytokine release.  Treatment 
with TSLP elicits increased frequencies of basophils which act on naïve CD4+ T 
cells to promote TH2 cell differentiation. Mast cells and basophils produce TSLP 
following stimulation. TSLP may also act on IECs to promote barrier function.   
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